Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5955348 A
Publication typeGrant
Application numberUS 08/977,306
Publication dateSep 21, 1999
Filing dateNov 25, 1997
Priority dateNov 25, 1997
Fee statusLapsed
Publication number08977306, 977306, US 5955348 A, US 5955348A, US-A-5955348, US5955348 A, US5955348A
InventorsJames Madison Ligon, Nancy R. Torkewitz, Dwight Steven Hill, Thomas Deane Gaffney, Jill Michelle Stafford
Original AssigneeNovartis Ag
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Genetically modified pseudomonas strains with enhanced biocontrol activity
US 5955348 A
Abstract
Strains of Pseudomonas have been genetically engineered to have enhanced biocontrol properties. The strains of the invention are particularly effective against plant pathogenic fungi such as species of Rhizoctonia and Pythium, because the strains produce enhanced amounts of antifungal metabolites such as pyrrolnitrin that are active against these fungal pathogens. Both the genetically modified biocontrol strains and the antifungal metabolites can be used as active agents for biocontrol compositions.
Images(33)
Previous page
Next page
Claims(28)
What is claimed is:
1. A biocontrol strain of Pseudomonas fluorescens selected front the group consisting of: CGA364474, CGA364475, CGA366259, CGA376150, NOA402208, NOA402210, NOA402212, NOA402214, NOA402216, NOA409063, NOA409068, NOA413174, NOA413175, NOA413176, NOA413177, NOA413178; or pyrrolnitrin producing progeny thereof.
2. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol strain of claim 1 to an environment in which the plant pathogenic fungus may grow.
3. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol strain of claim 1 to a plant or plant part in order to protect said plant or plant part from a plant pathogenic fungus.
4. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol strain of claim 1 to seed in order to protect a plant that develops from said seed from a plant pathogenic fungus.
5. The method of claim 2, wherein said plant pathogenic fungus is Rhizoctonia or Pythium.
6. The method of claim 3, wherein said plant pathogenic fungus is Rhizoctonia or Pythium.
7. The method of claim 4, wherein said plant pathogenic fungus is Rhizoctonia or Pythium.
8. A biocontrol composition comprising the biocontrol strain of claim 1 in combination with a chemical fungicide.
9. The biocontrol composition of claim 8, wherein said chemical fungicide is a metalaxyl compound.
10. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol composition of claim 8 to an environment in which the plant pathogenic fungus may grow.
11. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol composition of claim 8 to a plant or plant part in order to protect said plant or plant part from a plant pathogenic fungus.
12. A method for controlling or inhibiting the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol composition of claim 8 to seed in order to protect a plant that develops from said seed from a plant pathogenic fungus.
13. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is CGA364474 or pyrrolnitrin producing progeny thereof.
14. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is CGA364475 or pyrrolnitrin producing progeny thereof.
15. A biocontrol strain or Pseudomonas fluorescens according to claim 1, which is CGA366259 or pyrrolnitrin producing progeny thereof.
16. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is CGA376150 or pyrrolnitrin producing progeny thereof.
17. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA402208 or pyrrolnitrin producing progeny thereof.
18. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA402210 or pyrrolnitrin producing progeny thereof.
19. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA402212 or pyrrolnitrin producing progeny thereof.
20. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA402214 or pyrrolnitrin producing progeny thereof.
21. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA402216 or pyrrolnitrin producing progeny thereof.
22. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA409063 or pyrrolnitrin producing progeny thereof.
23. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA409068 or pyrrolnitrin producing progeny thereof.
24. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA413174 or pyrrolnitrin producing progeny thereof.
25. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA413175 or pyrrolnitrin producing progeny thereof.
26. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA413176 or pyrrolnitrin producing progeny thereof.
27. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA413177 or pyrrolnitrin producing progeny thereof.
28. A biocontrol strain of Pseudomonas fluorescens according to claim 1, which is NOA413178 or pyrrolnitrin producing progeny thereof.
Description
FIELD OF THE INVENTION

The present invention relates to genetically modified strains of Pseudomonas that have improved biocontrol properties. More specifically it relates to strains that are effective against plant pathogenic fungi.

BACKGROUND OF THE INVENTION

It has been recognized that crops grown in some soils are naturally resistant to certain fungal pathogens. Furthermore, soils that are conducive to the development of these diseases can be rendered suppressive or resistant to the pathogen by the addition of small quantities of soil from a suppressive field (Scher and Baker (1980) Phytopathology 70: 412-417). Conversely, suppressive soils can be made conducive to fungal disease susceptibility by autoclaving, indicating that the factors responsible for disease control are biological. Subsequent research has demonstrated that root colonizing bacteria are responsible for this phenomenon, which is known as biological disease control (Cook and Baker (1983), The Nature and Practice of Biological Control of Plant Pathogens; Amer. Phytopathol. Soc., St. Paul, Minn.).

In many cases, the most efficient strains of biological disease controlling bacteria are fluorescent pseudomonads (Weller et al. (1983) Phytopathology, 73: 463-469). These bacteria have also been shown to promote plant growth in the absence of a specific fungal pathogen by the suppression of detrimental rhizosphere microflora present in most soils (Kloepper et al. (1981) Phytopathology 71: 1020-1024). Important plant pathogens that have been effectively controlled by seed inoculation with these bacteria include Gaemannomyces graminis, the causative agent of take-all in wheat (Cook et al. (1976) Soil Biol. Biochem 8: 269-273) and Pythium and Rhizoctonia, pathogens that cause damping off of cotton (Howell et al. (1979) Phytopathology 69: 480-482). Rhizoctonia is a particularly problematic plant pathogen for several reasons. First, it is capable of infecting a wide range of crop plants, and second, there are no commercially available chemical fungicides that are effective in controlling the fungus.

Many biological disease controlling Pseudomonas strains produce antibiotics that inhibit the growth of fungal pathogens (Howell et al. (1979) Phytopathology 69:480-482; Howell et al. (1980) Phytopathology 70: 712-715). These antibiotics have been implicated in the control of fungal pathogens in the rhizosphere. For example, Howell et al. (Phytopathology 69: 480-482; 1979) disclose a strain of Pseudomonas fluorescens that produces an antibiotic substance antagonistic to Rhizoctonia solani. In addition, other strains of Pseudomonas fluorescens having enhanced biocontrol activity against plant pathogenic fungi such as Rhizoctonia and Pythium are disclosed in U.S. Pat. Nos. 5,348,742 and 5,496,547, both of which are hereby incorporated by reference in their entireties. Several other past studies have focused on the effects of mutations that result in the inability of the disease control bacterium to synthesize these antibiotics (Kloepper et al. (1981) Phytopathology 71: 1020-1024; Howell et al. (1983) Can. J. Microbiol. 29: 321-324). In these cases, the ability of the organism to control the pathogen is reduced, but not eliminated.

A particularly effective antibiotic against fungal pathogens is pyrrolnitrin, which is biosynthesized from tryptophan (Chang et al. J. Antibiot. 34: 555-566). Pyrrolnitrin is a phenylpyrrole derivative with strong antibiotic activity that has been shown to inhibit a broad range of fungi (Homma et al., Soil Biol. Biochem. 21: 723-728 (1989); Nishida et al., J. Antibiot., ser. A, 18: 211-219 (1965)). Pyrrolnitrin was originally isolated from Pseudomonas pyrrocinia (Arima et al, J. Antibiot., ser. A, 18: 201-204 (1965)), but has since been isolated from Myxococcus species, Burkholdaria species, and several other Pseudomonas species such as PS. FLUORESCENS (Gerth et al. J. Antibiot. 35: 1101-1103 (1982); J. N. Roitman, N. E. Mahoney and W. J. Janisiewicz, Applied Microbiology and Biotechnology 34:381-386 (1990)). The compound has been reported to inhibit fungal respiratory electron transport (Tripathi & Gottlieb, J. Bacteriol. 100: 310-318 (1969)) and uncouple oxidative phosphorylation (Lambowitz & Slayman, J. Bacteriol. 112: 1020-1022 (1972)). It has also been proposed that pyrrolnitrin causes generalized lipoprotein membrane damage (Nose & Arima, J. Antibiot., ser A, 22: 135-143 (1969); Carlone & Scannerini, Mycopahtologia et Mycologia Applicata 53: 111-123 (1974)). U.S. Pat. No. 5,639,949 and U.S. Pat. No. 5,817,502, both of which are hereby incorporated by reference in their entireties, describe the cloning and characterization of the pyrrolnitrin biosynthetic genes from Ps. fluorescens and Ps. pyrrocinia.

An important factor in biological control is the ability of a biocontrol organism to compete in a given environment (Baker et al. (1982) Biological Control of Plant Pathogens, American Phytopathological Society, St. Paul, Minn., pages 61-106). Thus, it is desirable to obtain strains of biocontrol agents that effectively control the growth of fungal pathogens such as Rhizoctonia and Pythium and that are also able to aggressively compete with indigenous bacteria and microflora existing in the rhizosphere of the plant.

SUMMARY OF THE INVENTION

The present invention is drawn to genetically engineered biocontrol strains of Pseudomonas that are able to effectively control pathogenic attack on crop plants. Preferred biocontrol strains include the following strains of Pseudomonas fluorescens, which are described in detail in the examples below: CGA376146, CGA364473, CGA375258, CGA376148, CGA364476, CGA375260, CGA375259, CGA378584, CGA267pPhz, CGA364474, CGA364475, CGA366259, CGA376150, NOA402208, NOA402212, NOA402214, NOA402216, CGA267356/Phl, NOA409068, NOA413174, NOA413175, NOA413176, NOA413177, and NOA413178. The biocontrol strains of the invention produce at least one antifungal substance that is capable of inhibiting a broad spectrum of plant pathogens such as Rhizoctonia and Pythium. In a preferred embodiment, the biocontrol strains of the invention produce enhanced quantities of pyrrolnitrin; see, e.g., Table 1. As shown in Table 2, such strains have increased biocontrol properties and are able to aggressively compete in the plant rhizosphere. The genotypes of the biocontrol strains of the invention are summarized in Table 3 and deposit information for the biocontrol strains of the invention is given in Table 4. The present invention is also intended to encompass pyrrolnitrin producing strains derived from the above-listed strains.

The present invention is also drawn to biocontrol compositions comprising the biocontrol strains of the invention in combination with a chemical fungicide such as a metalaxyl compound. In addition, methods of making the biocontrol strains as well as methods of using the strains and biocontrol compositions for control of pathogenic attack on crops are described.

BRIEF DESCRIPTION OF THE SEQUENCES IN THE SEQUENCE LISTING

SEQ ID NO:1 is the nucleotide sequence of the 11 kb EcoRI fragment containing the gacA gene and derived from the chromosome of Pseudomonas fluorescens strain CGA267356. The coding sequences in this sequence include genes encoding: a methyltransferase (bases 210-1688) with homology to the cheR and frzF genes from E. coli and Myxococcus xanthus, respectively; a sensor kinase (bases 1906-3633) with homology to the rcsC, frzE and bvgS genes of E. coli, M. xanthus, and Borditella pertussis, respectively; a tRNA (bases 4616-4691, complementary DNA strand) with homology to glyW from E. coli; CDP-diacylglycerol-glycerol-3-phosphate-3-phosphatidyltransferase (bases 4731-5318, complementary DNA strand) with homology to pgsA; UVR exonuclease subunit C (bases 5574-7397, complementary DNA strand) with homology to uvrC; and a response regulator/transcription activator (gacA; bases 7400-8041, complementary DNA strand) with homology to the uvrY and GACA genes of E. coli and P. fluorescens, respectively.

SEQ ID NO:2 is the nucleotide sequence of the native gacA regulatory gene.

SEQ ID NO:3 is the protein sequence encoded by the native gacA regulatory gene.

SEQ ID NO:4 is the nucleotide sequence of the ATG-gacA regulatory gene, wherein the first base in the coding sequence has been changed from the native thymidine (T) to an adenine (A) to create the more efficient ATG translation initiation codon.

SEQ ID NO:5 is the protein sequence encoded by the altered ATG-gacA regulatory gene.

SEQ ID NO:6 is the nucleotide sequence of the pyrrolnitrin gene cluster.

SEQ ID NO:7 is the nucleotide sequence of the tac promoter/rrnB transcription terminator cassette.

SEQ ID NO:8 is the nucleotide sequence of the lemA gene.

SEQ ID NO:9 is the nucleotide sequence of the gac*3 regulatory gene, wherein the adenine (A) base at position 395 has been changed from the native adenine (A) to a guanine (G) so that codon 132 encodes an arginine residue instead of the usual glutamine.

SEQ ID NO:10 is the protein sequence encoded by the altered gac*3 regulatory gene.

SEQ ID NO:11 is the nucleotide sequence of the phenazine gene cluster.

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides improved biocontrol strains of Pseudomonas that can be used to control pathogenic attack on crop plants. Such strains are able to aggressively compete in the plant rhizosphere as well as produce one or more antifungal substances that are effective against a broad spectrum of plant pathogenic fungi such as Rhizoctonia and Pythium.

The biocontrol strains of the present invention are important for several reasons. First, Rhizoctonia such as Rhizoctonia solani are particularly pernicious plant pathogens. The affected plants include beans, wheat, tomato and potato, in addition to cotton. Second, there are few environmentally safe and effective fungicide treatments available for the protection of crops from Rhizoctonia. Therefore, the use of the disclosed biocontrol strains to control or prevent Rhizoctonia infections in crop plants provides an environmentally safe and effective method of controlling this and other plant pathogens.

Pseudomonas fluorescens strain CGA267356 (also known as both MOCG134 and BL915) has been shown to be effective in controlling plant pathogenic fungi such as Rhizoctonia and Pythium. Strain CGA267356 is one of the subjects of U.S. Pat. No. 5,348,742. Two mutants of CGA267356, strains CGA321730 (a.k.a. MOCG134-8392) and CGA319115, have been constructed and shown to demonstrate even better biological control (biocontrol) of these phytopathogens. CGA321730 and CGA319115 are the subject of U.S. Pat. No. 5,496,547.

Two genes have been isolated from strain CGA267356 that encode proteins that regulate the synthesis of several antifungal compounds produced by the strain, including the antifungal metabolite pyrrolnitrin (prn). These are the lemA gene and gafA (a.k.a. gacA) gene that encode sensor kinase and response regulator proteins, respectively, which function as a typical two-component bacterial regulatory system. These genes and their use to activate biocontrol activity in biocontrol strains are described in U.S. Pat. No. 5,670,350, which is hereby incorporated by reference in its entirety. In addition, U.S. Pat. No. 5,639,949 and U.S. Pat. No. 5,817,502 describe a four gene cluster isolated from strain CGA267356 that encodes proteins that direct the biosynthesis of pyrrolnitrin.

In the present invention, the lemA and gacA regulatory genes and the pyrrolnitrin biosynthetic genes have been utilized to genetically modify parent Ps. fluorescens strain CGA267356 to construct altered strains that demonstrate enhanced production of antifungal metabolites, i.e. pyrrolnitrin, and accordingly enhanced biocontrol activity. In addition, genes from Pseudomonas aureofaciens strain 30-84 that are involved in the synthesis of the antifungal metabolite phenazine-1-carboxylic acid (PCA) have been utilized to genetically modify parent Ps. fluorescens strain CGA267356 to produce PCA, thereby improving the biocontrol activity of strain CGA267356.

A further embodiment of the invention provides a method for controlling or inhibiting the growth of a plant pathogenic fungus by applying the genetically engineered biocontrol strains of the invention to an environment in which the plant pathogenic fungus may grow. This can be to the plant/s or parts of the plant/s (before or after harvest) or to the seeds (prior to planting) of the plant/s to be protected, or alternatively to soil in which the plant/s to be protected are growing or will grow. The biocontrol strains are applied in an effective amount; that is, in an amount sufficient to control or inhibit the pathogen. The rate of application may vary according to the crop to be protected, the efficacy of the biocontrol strain, the pathogen to be controlled, and the severity of the disease pressure. Generally, the rate of application is about 1.3105 cfu/cm to about 1.31010 cfu/cm, specifically about 1.3106 cfu/cm to about 1.3109 cfu/cm, more specifically about 1.3107 cfu/cm to about 1.3108 cfu/cm.

A more particular embodiment of the present invention provides methods of inhibiting the growth of Rhizoctonia and Pythium by applying the biocontrol strains of the invention to environments in which the plant pathogenic fungi may grow. This can be to the plant/s or parts of the plant/s (before or after harvest) or to the seeds (prior to planting) of the plant/s to be protected, or alternatively to soil in which the plant/s to be protected are growing or will grow. As noted above, the rate of application varies depending on various factors. However, the general rate of application is about 1.3105 cfu/cm to about 5109 cfu/cm, specifically about 1.3106 cfu/cm to about 1.3109 cfu/cm more specifically about 1.3107 cfu/cm to about 1.3108 cfu/cm.

The recombinant biocontrol strains of the present invention may be used in any manner known in the art, including coating seeds with an effective amount of the biocontrol strains, in furrow application of the biocontrol strains directly into the soil, in foliar application, and in post-harvest disease control. Such methods are well known in the art and are described, for example, in U.S. Pat. No. 5,348,742 and in the published European Application EP 0 472 494 A2, which is hereby incorporated by reference. Furthermore, the strains of this application can also be mixed in formulation with known pesticides in a manner described in WO 94/10845, which disclosure is herein incorporated by reference.

EXAMPLES

The invention is illustrated in further detail by the following detailed procedures, preparations, and examples. The examples are for illustration only, and are not to be construed as limiting the scope of the present invention. Standard recombinant DNA and molecular cloning techniques used here are well known in the art and are described by Sambrook, et al., Molecular Cloning, eds., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1989) and by T. J. Silhavy, M. L. Berman, and L. W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1984) and by Ausubel, F. M. et al., Current Protocols in Molecular Biology, pub. by Greene Publishing Assoc. and Wiley-Interscience (1987).

Example 1 Construction of Strain CGA376146 (MONO571) (CGA321730, pE11)

Strain CGA376146 (a.k.a. MONO571) was constructed by introducing plasmid pE11 into P.fluorescens strain CGA321730 (a.k.a. MOCG-0134-8392) by conjugation. Strain CGA321730 is described in U.S. Pat. No. 5,496,547 and is a transposon mutant of wild-type P. fluorescens strain CGA267356 (U.S. Pat. No. 5,348,742) that has enhanced biocontrol activity over the wild-type strain. Strain CGA267356 has been deposited with the ATCC and assigned ATCC accession number 55169. Strain CGA321730 has been deposited with the NRRL and assigned accession number NRRL B-21173. Plasmid pE11 (U.S. Pat. No. 5,670,350) was constructed by ligating the 11 kilobase (kb) EcoRI fragment derived from the chromosome of strain CGA267356 into the broad host range plasmid vector pRK290 (Ditta et al., Proc. Natl. Acad. Sci. USA 77:7347-7351 (1980). Plasmid pE11 has been deposited with ATCC and has been assigned ATCC accession number 40869.

The 11-kb EcoRI fragment contains the gacA (gafA) gene that encodes a response regulator protein known to regulate the synthesis of antifungal compounds. This 11-kb EcoRI fragment is described in U.S. Pat. No. 5,670,350 and is set forth herein as SEQ ID NO:1. The plasmid vector, pRK290, used in constructing pE11, is derived from native Pseudomonas plasmids. It is mobilizable but not self-transmissible by conjugation and it carries a tetracycline resistance gene (Ditta et al., 1980).

New strain CGA376146 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strains CGA267356 and CGA321730. New strain CGA376146 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21811.

Example 2 Construction of Strain CGA364473 (MONO517) (ATG-gacA)

P. fluorescens strain CGA364473 (a.k.a. MONO517) was derived from parent P. fluorescens strain CGA267356 by changing a single base in the chromosome of the parent strain.

The native gacA regulatory gene begins with the unusual TTG translation initiation codon (SEQ ID NO:2). All proteins in nature are synthesized with methionine as the first amino acid on the amino terminus and ATG is the only codon that encodes methionine. Therefore, the normal translation initiation codon for most genes is ATG. Alternate translation initiation codons GTG and TTG will also result in the incorporation of methionine as the first amino acid since methionine must always be the first amino acid in a newly synthesized protein, but they usually cause a reduction in the efficiency of translation. As a result, fewer protein molecules are made from the same amount of messenger RNA.

To create strain CGA364473, the first base in the coding sequence of the gacA gene was changed from a thymidine (T) to an adenine (A) to create the more efficient ATG translation initiation codon (SEQ ID NO:4). This change was created in vitro by PCR technology and the native gacA gene in the chromosome of strain CGA267356 was replaced with the ATG/gacA gene by homologous gene replacement. The amino acid sequence of the GacA protein encoded by this altered gacA gene (SEQ ID NO:5) is identical to that encoded by the native gene (SEQ ID NO:3), but translation should be more efficient, resulting in synthesis of higher amounts of the protein.

New strain CGA364473 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to strain CGA267356. New strain CGA364473 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21812.

Example 3 Construction of Strain CGA375258 (MONO568) (pPrn)

Strain CGA375258 (a.k.a. MONO568) was created by introducing plasmid pPrn into the parent P. fluorescens strain CGA267356. Plasmid pPrn was constructed by cloning a 6.2 kb XbaI/NotI gene fragment from plasmid pCIB 169 (which was derived from P. fluorescens strain CGA267356) into the expression vector pKK223-3, as described in Examples 7-11 of U.S. Pat. No. 5,639,949 and U.S. Pat. No. 5,817,502 (See SEQ ID NO:6). Plasmid pCIB 169 has been deposited with the NRRL and assigned accession number NRRL B-21256. The 6.2 kb XbaI/NotI gene fragment of SEQ ID NO:6 contains the prnABCD gene cluster that encodes genes for the biosynthesis of pyrrolnitrin as described in U.S. Pat. No. 5,639,949 and Ser. No. 08/729,214. A 6.9 kb BglII fragment containing the prnABCD gene cluster with the tac promoter (see SEQ ID NO:7) upstream of the gene cluster and the rrnB transcription terminator (SEQ ID NO:7) derived from plasmid pKK223-3 downstream of the cluster was subsequently cloned into the BglII site of plasmid pRK290 to create plasmid pPrn.

The tac promoter is a small DNA fragment (less than 100 bases) derived from E. coli, which is known to be a regulatory element or promoter (Amann, et al, Gene 25:167-178 (1983)) that does not itself encode a protein product. SEQ ID NO:7 presents the sequence of the BssHII DNA fragment containing the tac promoter and the rrnB transcription terminator derived from plasmid pKK223-3. The tac promoter is known to be highly expressed in a constitutive manner in Pseudomonas. Its use with the prn genes causes constitutive, high-level expression of these genes. On the other hand, in the native strain, the promoter for the pyrrolnitrin genes is regulated by the gacA gene product; accordingly, the pyrrolnitrin genes are expressed in the native strain only in the stationary phase of growth.

New strain CGA375258 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strain CGA267356. New strain CGA375258 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21813.

Example 4 Construction of Strain CGA376148 (MONO573) (CGA321730, pPrn)

The chromosomal background of strain CGA376148 (a.k.a. MONO573) is the same as strain CGA376146 (Example 1). In addition, strain CGA376148 contains the plasmid pPrn (Example 3) that carries the tac promoter fused to the prnABCD gene cluster.

New strain CGA376148 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strain CGA267356. New strain CGA376148 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21814.

Example 5 Construction of Strain CGA364476 (MONO520) (pLem/Gac)

Strain CGA364476 (a.k.a. MONO520) is the same as wild-type strain CGA267356, except that strain CGA364476 also contains a plasmid with the lemA and gacA genes derived from the chromosome of the wild-type strain CGA267356.

The plasmid containing the lemA and gacA genes, pLem/Gac, was constructed as follows: The plasmid pCIB 146 (Examples 20 and 21 and FIG. 4 of U.S. Pat. No. 5,670,350) contains about 25-kb of chromosomal DNA from strain CGA267356. The lemA gene (see SEQ ID NO:8) has been described and shown to be located in this DNA. The subcloned DNA in pCIB 146 is flanked on each side by NotI and EcoRI sites. An approximately 16-kb HindIII/NotI fragment from pCIB 146, which contains the lemA gene, was excised from pCIB 146. The NotI end was converted to a HindIII site to facilitate cloning of the fragment into the unique HindIII fragment of plasmid pE11 (Example 1), which contains the gacA gene. Insertion of the 16-kb lemA-containing HindIII fragment into the HindIII site of pE11 did not disrupt the function of the gacA gene, because the HindIII site is not within its coding sequence.

New strain CGA364476 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strain CGA267356. New strain CGA364476 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21815.

Example 6 Construction of Strain CGA375260 (MONO570) (gac*3)

Strain CGA375260 (a.k.a. MONO570) differs from the parent strain CGA267356 by a single base change within the coding sequence of the native gacA gene (SEQ ID NO:2). This modification was generated by introducing the native gacA gene into the hypermutagenic E. coli strain XL1-Red (from Stratagene, Inc.). The plasmid was recovered and introduced into a lemA mutant of strain CGA267356 that also contained lacZY genes inserted into an unknown chromosomal gene whose expression is regulated by LemA and GacA. Clones containing randomly mutated gacA genes that resulted in expression of the lacZY genes, as indicated by the formation of blue colonies on agar containing X-Gal, were further analyzed. These clones contained gacA genes that did not require phosphorylation by LemA in order to be active as a transcriptional activator. Three such gacA genes were isolated in this manner and the nucleotide sequence of each was determined. In each, there was a different single base change that resulted in a different single amino acid change in the encoded GacA protein. Each of the three modified gacA genes were used to replace the native gacA gene in strain CGA267356 by perfect site replacement mediated through homologous recombination.

Of the three, only one clone with a LemA-independent gacA gene (gac*3) was shown to have enhanced pyrrolnitrin synthesis and biocontrol activity (Tables 1 and 2). The nucleotide sequence of the gac*3 gene of this clone, CGA375260, was determined (SEQ ID NO:9) and it was found that a single base change occurs in codon 132, which is CAG and encodes a glutamine residue in the native GacA protein. The adenine base in this codon was changed to guanine to create a codon that encodes an arginine residue (CGG) in the altered strain. Therefore, the GacA protein (SEQ ID NO:10) in this strain has an arginine at amino acid 132 instead of the usual glutamine. In all other respects, this strain is identical to the parent strain. In the normal regulatory system and under the proper conditions, the LemA protein phosphorylates GacA and in the phosphorylated state it activates transcription of genes involved in the synthesis of antifungal compounds. This single base change in the GacA protein renders it active irrespective of the kinase activity of the LemA protein.

New strain CGA375260 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21816.

Example 7 Construction of Strain CGA375259 (MONO569) (tac/gacA, pPrn)

Strain CGA375259 (a.k.a. MONO569) was derived from strain CGA267356 by replacement of the native promoter controlling expression of the chromosomal gacA gene with the tac promoter from E. coli (Example 3) and introduction of plasmid pPrn (Example 3).

The promoter of the gacA gene was replaced with the tac promoter as follows: A unique NruI site in the 2-kb XhoI gacA gene-containing fragment of pCIB 137 (Examples 6 and 7 of U.S. Pat. No. 5,670,350) located 12-bp upstream of the translation start site of the gacA gene was modified by PCR to change it to a BamHI site. Plasmid pCIB 137 has been deposited with the NRRL and assigned accession number NRRL B-18981. A second BamHI site was inserted immediately 5' to the gacA translation start site using PCR. This created a small BamHI fragment immediately preceding the gacA coding sequence. This short BamHI fragment was excised and the DNA was religated to create a new BamHI site. The tac promoter was excised from plasmid pKK223-3 (SEQ ID NO:7) as a BglII/BamHI fragment and cloned in the appropriate orientation into the new BamHI site 5' to the beginning of the gacA gene, which was created by the excision of the above short BamHI fragment. This tac promoter/gacA gene (tac/gacA) fragment was excised as an XhoI fragment and was used to replace the native gacA gene on the 2-kb XhoI site in a plasmid containing the HindIII/EcoRI fragment from pE11. This plasmid was introduced into a gacA deletion mutant of strain CGA267356 (Example 9 of U.S. Pat. No. 5,670,350). Perfect replacement clones were generated (Example 9 of U.S. Pat. No. 5,670,350) and selected by restoration of the wild-type colony morphology. The newly inserted tac/gacA gene resulted in a higher level of expression of the gacA gene, compared to the low level of expression from the native gacA gene promoter.

Plasmid pPrn described in Example 3 above was subsequently introduced into the strain containing the tac/gacA gene to make strain CGA375259.

New strain CGA375259 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strain CGA267356. New strain CGA375259 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21817.

Example 8 Construction of Strain CGA378584 (MONO591) (cPrn, pLem/Gac)

Strain CGA378584 (a.k.a. MONO591) contains the tac/prnABCD gene cluster described in Example 3 in the chromosome and it also contains plasmid pLem/Gac described in Example 5.

The tac/prnABCD genes were inserted in the chromosome of strain CGA267356 by modification of the E. coli cloning vector pKK223-3 by adding a kanamycin resistance gene derived from plasmid pUC4K (Pharmacea) into the PstI site of the multiple cloning site and by removing the EcoRI, NotI, and BamHI sites of pKK223-3. A 16-kb KpnI gene fragment derived from pCIB 169 (FIG. 4 of U.S. Pat. No. 5,639,949) was cloned into the modified pKK223-3. Plasmid pCIB 169 has been deposited with the NRRL and assigned accession number NRRL B-21256.

The prnABCD genes were deleted by digestion of the plasmid with EcoRI and NotI, conversion of the EcoRI and NotI ends to BamHI by fill-in, linkering, and religation. The 6.9-kb BglII fragment (Example 3), which contains the tac promoter/prnABCD/rrnB terminator construction, was ligated into the BamHI site, thus introducing these modified genes into the plasmid. This plasmid was introduced into strain CGA267356 by conjugation and the native prnABCD gene cluster was replaced with the tac promoter/prnABCD/rrnB terminator construct by homologous recombination.

Plasmid pLem/Gac (Example 5) was introduced into the strain with the chromosomally located tac promoter/prnABCD/rrnB terminator to create strain CGA378584.

New strain CGA378584 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to have higher biocontrol activity (Table 2) compared to the related strain CGA267356. New strain CGA378584 was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21818.

Example 9 Construction of Strain CGA267pPhz (MONO597) (pPhz)

This strain is the same as Pseudomonas strain CGA267356, except that strain CGA267pPhz (a.k.a. MONO597) contains a plasmid carrying DNA from Pseudomonas aureofaciens strain 30-84 that contains 5 genes known to encode the pathway for the biosynthesis of the antifungal metabolite phenazine-1-carboxylic acid (PCA).

A 5.7-kb EcoRI/HindIII gene fragment (SEQ ID NO:11) containing the phzFABCD gene cluster from P. aureofaciens (Pierson, et al., FEMS Microbiol. Lett. 134:299-307 (1995)) was ligated into DNA of plasmid pUCP26 (West, et al., Gene 128:81-86 (1994)) that had been restricted with EcoRI and HindIII to create plasmid pPhz. Plasmid pUCP26 is an E. coli/Pseudomonas shuttle plasmid that has a lac promoter flanking the multiple cloning site. The EcoRI and HindIII sites are oriented with the lac promoter such that the EcoRI site is closer to the promoter. Therefore, cloning of the EcoRI/HindIII phzFABCD gene fragment, in which the phz genes are cotranscribed on a single operon oriented in the EcoRI to HindIII direction into plasmid pUCP26, results in the proper juxtaposition of the lac promoter and phz gene cluster to cause expression of these genes from that promoter.

New strain CGA267pPhz has been shown to produce PCA, an antifungal metabolite not normally produced by parent strain CGA267356. It also produces the metabolites normally produced by the parent strain, including pyrrolnitrin. New strain CGA267pPhz was deposited with the NRRL on Sep. 5, 1997, and assigned accession no. NRRL B-21819.

Example 10 Construction of Strain CGA364474 (MONO518) (lac/gacA)

Strain CGA364474 (a.k.a. MONO518) was constructed by juxtaposition of the lac promoter element from E. coli (de Boer et al., Proc. Natl. Acad. Sci. USA 80:21-25 (1983)) with the gacA gene (SEQ ID NO:2) residing in the chromosome of P. fluorescens strain CGA267356 (U.S. Pat. No. 5,348,742) such that expression of the gacA gene is regulated by the lac promoter. The lac promoter is a small DNA fragment that is known to promote gene expression and does not itself encode a protein product. It provides strong, constitutive expression of genes in Pseudomonas. The lac promoter and the gacA gene were fused precisely by overlapping PCR and the lac/gacA promoter/gene DNA fragment replaced the native gacA gene in the chromosome of strain CGA267356 by homologous recombination.

Strain CGA364474 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to provide higher biocontrol activity (Table 2) than parent strain CGA267356. New strain CGA364474 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21887.

Example 11 Construction of Strain CGA364475 (MONO519) (tac/prnABCD)

P. fluorescens strain CGA364475 (a.k.a. MONO519) was derived from the parent P. fluorescens strain CGA267356 by juxtaposition of the tac promoter element from E. coli (Example 3, SEQ ID NO:7) with the prnABCD gene cluster (U.S. Pat. No. 5,639,949) in the chromosome such that expression of the prnABCD genes is from the tac promoter. In strain CGA364475, the prnABCD genes are expressed from the strong, constitutive tac promoter rather than the weaker, regulated native prn gene promoter. As a result, this strain produces more of the antifungal metabolite pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. New strain CGA364475 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21888.

Example 12 Construction of Strain CGA366259 (MONO524) (tac/prnABCD, pE11)

Strain CGA366259 (a.k.a. MONO524) was created by introducing plasmid pE11 (Example 1) containing the native gacA gene derived from P. fluorescens strain CGA267356 into P. fluorescens strain CGA364475 (Example 11) by conjugation. New strain CGA366259 has been shown to produce higher amounts of the antifungal metabolite pyrrolnitrin (Table 1) and to provide greater biocontrol activity (Table 2) than parent strain CGA267356. New strain CGA366259 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21889.

Example 13 Construction of Strain CGA376150 (MONO575) (CGA267355, pE11)

Strain CGA376150 (a.k.a. MONO575) was constructed by introducing plasmid pE11 (Example 1) into the wild-type P. fluorescens strain CGA267355 by conjugation. Strain CGA267355 was isolated from soil in Texas. It normally does not produce the antifungal metabolites pyrrolnitrin and 2-hexyl-5-propyl-resorcinol, or the hydrolytic enzyme chitinase. However, upon the introduction of plasmid pE11 containing the gacA gene, strain CGA376150 was demonstrated to produce pyrrolnitrin (Table 1), 2-hexyl-5-propyl-resorcinol, and chitinase and was shown to be an effective biocontrol agent (Table 2). New strain CGA376150 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21890.

Example 14 Construction of Strain NOA402208 (MONO630) (gac*3, pPrn)

Strain NOA402208 (a.k.a. MONO630) was constructed by introducing the plasmid pPrn containing the prnABCD gene cluster under the control of the tac promoter (Example 3) into P. fluorescens strain CGA375260 (Example 6) by conjugation. Strain CGA375260 differs from the parent strain CGA267356 by a single base change in the gacA coding sequence (SEQ ID NO:9) that renders GacA (SEQ ID NO:10), the protein product of the modified gacA gene and an activator of transcription, active irrespective of phosphorylation by the LemA protein. As a result, strain NOA402208 produces more pyrrolnitrin (Table 1) and has greater biocontrol activity (Table 2) than parent strain CGA267356. New strain NOA402208 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21891.

Example 15 Construction of Pseudomonas fluorescens Strain NOA402210 (MONO632) (res-, pPrn)

Strain NOA402210 (a.k.a. MONO632) was constructed from P. fluorescens strain CGA267356 (U.S. Pat. No. 5,348,742) by deletion of a region of the chromosome that resulted in no production of the antimicrobial metabolite 2-hexyl-5-propyl-resorcinol and introduction of the plasmid pPrn by conjugation.

P. fluorescens strain CGA319115 is a transposon mutant of the parent strain CGA267356 that is incapable of the production of 2-hexyl-5-propyl-resorcinol and that provides greater biocontrol activity compared to strain CGA267356. A cosmid clone, BL3610, from a gene library of DNA from strain CGA267356 was found that restores production of 2-hexyl-5-propyl-resorcinol to strain CGA319115. An in vivo marker exchange was performed with cosmid clone BL3610 in strain CGA319115 in order to rescue the transposon and the flanking DNA. The cosmid clone BL3610Tn containing the mutagenized genomic DNA from strain CGA319115 with the transposon was thus isolated. A 6.5 kilobase pair (kb) EcoRI DNA fragment from cosmid BL3610 that corresponded to the region in cosmid BL3610Tn that contained the transposon insertion was cloned into plasmid pBluescript II (Phannacea, Inc.) to create plasmid pBL3632.

The DNA sequence of this fragment and the DNA flanking the transposon in strain CGA319115 were determined and compared to reveal the precise location of the transposon insertion in the 6.5 kb DNA fragment. Two unique BclI restriction sites approximately 200 base pairs apart and flanking the transposon insertion site were identified within this region, and the DNA between these sites was deleted by restriction with BclI and religation. A 4.0 kb XhoI DNA fragment derived from the 6.5 kb EcoRI fragment of pBL3632 and containing the deletion of the 200 base pair BclI fragment was cloned into a plasmid vector to facilitate homologous exchange in strain CGA267356. Homologous exchange between this plasmid and the chromosome of strain CGA267356 resulted in replacement of the wild-type region in the chromosome with the deleted DNA of the plasmid, thereby rendering the strain incapable of producing 2-hexyl-5-propyl-resorcinol. Southern hybridization was performed to confirm that the BclI fragment was absent.

This 2-hexyl-5-propyl-resorcinol non-producing deletion mutant of P. fluorescens strain CGA267356 was given the strain name NOA402209. Strain NOA402210 was created by introducing plasmid pPrn containing the prnABCD gene cluster under the control of the tac promoter into strain NOA402209.

Strain NOA402210 produces more pyrrolnitrin (Table 1) than the parent strain CGA267356 and it provides greater biocontrol activity (Table 2) compared to the parent strain. Strain NOA402210 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21901.

Example 16 Construction of Strain NOA402212 (MONO634) (gac*3, res-, pPrn)

Strain NOA402212 (a.k.a. MONO634) was constructed in a manner identical to that described for strain NOA402210 in Example 15 above, except that the strain used as the starting strain for NOA402212 was P. fluorescens strain CGA375260 (Example 6) instead of strain CGA267356.

Strain NOA402212 was created by introducing the deletion of the 200 bp BclI fragment into the chromosome of P. fluorescens strain CGA375260 to create strain NOA402211 and by the subsequent introduction of the plasmid pPrn containing the prnABCD gene cluster under the control of the tac promoter. This strain produces more pyrrolnitrin (Table 1) than either the parent strain CGA267356 or strain NOA402208 and it provides greater biocontrol activity (Table 2) compared to the parent strain.

Strain NOA402212 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21892.

Example 17 Construction of Strain NOA402214 (MONO636) (ATG-gacA, res-, pPrn)

Strain NOA402214 (a.k.a. MONO636) was constructed in a manner identical to that described for strain NOA402210 in Example 15 above, except that the strain used as the starting strain for NOA402214 was P. fluorescens strain CGA364473 (Example 2) instead of strain CGA267356.

Strain CGA364473 is identical to strain CGA267356 except for a single base change in the coding sequence of the gacA gene. The gacA gene was noted to have the unusual TTG translation start codon. In order to improve translational efficiency of the gacA-specific mRNA, the first base in the coding sequence of the gacA gene was changed to an adenine (A), thus creating the normal ATG translation start codon (SEQ ID NO:4). Strain CGA364473 was further modified in the same manner as strain NOA402212 to contain the deletion of the 200 base pair BclI fragment, creating strain NOA402213, which does not produce 2-hexyl-5-propyl-resorcinol. Strain NOA402214 was created by introduction of the plasmid pPrn containing the prnABCD genes under the control of the tac promoter by conjugation into strain NOA402213.

Strain NOA402214 produces higher amounts of pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA402214 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21893.

Example 18 Construction of Strain NOA402216 (MONO638) (lac/ATG-gacA, res-, pPrn)

Strain NOA402216 (a.k.a. MONO638) contains a chromosomal gacA gene with an ATG translation start codon as in Example 17 that is expressed from the lac promoter of E. coli. It also contains a chromosomal deletion of the 200 base pair BclI fragment that results in a 2-hexyl-5-propyl-resorcinol non-producing phenotype. Finally, it contains the plasmid pPrn described in Example 14, which contains the prnABCD gene cluster under regulation of the tac promoter.

The ATG-gacA gene was fused to the lac promoter and integrated into the chromosome of P. fluorescens strain CGA267356 essentially as described in Example 7, except that the lac promoter was used instead of the tac promoter. The resulting strain containing the lac/ATG-gacA gene in its chromosome was converted to a 2-hexyl-5-propyl-resorcinol non-producing phenotype by the same method described for the construction of strain NOA402212 (Example 15) to create strain NOA402215. Finally, strain NOA402216 was constructed by introduction of the plasmid pPrn into strain NOA402215.

Strain NOA402216 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA402216 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21894.

Example 19 Construction of Strain NOA409063 (MONO686) (pGac*3/Prn)

Strain NOA409063 (a.k.a. MONO686) was constructed from the parent P. fluorescens strain CGA267356 by the introduction of a plasmid containing both the gac*3 and prnABCD genes. Plasmid pGac*3/Prn was constructed by cloning the prnABCD gene cluster under the control of the tac promoter as a 6.9 kb BglII fragment (Example 3) into the unique BglII site of the broad host-range plasmid pVK101 (Knauf, V. and Nester, E. Plasmid 8:45-54 (1982)) followed by cloning the gac*3 gene (Example 6) as an XhoI DNA fragment into the unique XhoI site. This plasmid was introduced into the parent P. fluorescens strain CGA267356 to create strain NOA409063. This strain produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than the parent strain CGA267356. Strain NOA409063 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21902.

Example 20 Construction of Strain NOA409068 (MONO691) (pKT-Prn)

Strain NOA409068 (a.k.a. MONO691) was constructed in a manner identical to that described for strain CGA375258 in Example 3 above, except that plasmid pKT231 was used in strain NOA409068 to maintain the exogenous DNA instead of the plasmid pRK290 used in strain CGA375258.

Strain NOA409068 was created by introducing plasmid pKT-Prn into parent P. fluorescens strain CGA267356 by conjugation. Plasmid pKT-Prn was constructed by cloning the 6.9 kb BglII fragment described in Example 3 containing the prnABCD gene cluster from strain CGA267356 with the tac promoter and rrnB transcription terminator, into the broad host-range plasmid pKT231 (Puhler, Vectors for Gram-negative Bacteria. 1985. Elsevier Scientific Publishers).

Strain NOA409068 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA409068 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21895.

Example 21 Construction of Strain NOA413174 (MONO706) (res-, pKT-Prn)

Strain NOA413174 (a.k.a. MONO706) was created by introduction of plasmid pKT-Prn (Example 20) by conjugation into the P. fluorescens 2-hexyl-5-propyl-resorcinol non-producing strain NOA402209 described in Example 15. Strain NOA413174 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) compared to parent strain CGA267356. Strain NOA413174 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21896.

Example 22 Construction of Strain NOA413175 (MONO707) (gac*3, pKT-Prn)

Strain NOA413175 (a.k.a. MONO707) was created by introduction of plasmid pKT-Prn (Example 20) by conjugation into the P. fluorescens strain CGA375260 (Example 6). Strain NOA413175 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA413175 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21897.

Example 23 Construction of Strain NOA413176 (MONO708) (gac*3, res-, pKT-Prn)

Strain NOA413176 (a.k.a. MONO708) was created by introduction of plasmid pKT-Prn (Example 20) by conjugation into P. fluorescens strain NOA402211 (described in Example 16). Strain NOA413176 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA413176 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21898.

Example 24 Construction of Strain NOA413177 (MONO709) (ATG-gacA, res-, pKT-Prn)

Strain NOA413177 (a.k.a. MONO709) was created by introduction of plasmid pKT-Prn by conjugation into P. fluorescens strain NOA402213 (described in Example 17). Strain NOA413177 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA413177 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21899.

Example 25 Construction of Strain NOA413178 (MONO710) (lac/ATG-gacA, res-, pKT-Prn)

Strain NOA413178 (a.k.a. MONO710) was created by introduction of plasmid pKT-Prn by conjugation into P. fluorescens strain NOA402215 (described in Example 18). Strain NOA413178 produces more pyrrolnitrin (Table 1) and provides greater biocontrol activity (Table 2) than parent strain CGA267356. Strain NOA413178 was deposited with the NRRL on Nov. 20, 1997, and assigned accession no. NRRL B-21900.

Example 26 Cultivation of Bacteria and Fungi for Screening Assays

a. Cultivation of Bacteria

The bacterial strains are stored in 20% glycerol at -80 C. prior to use. One loop from the stored culture is suspended in 5 ml Luria Broth (LB: 10 g Bacto-Tryptone, Difco; 5 g yeast extract, Oxoid; 0.25 g MgSO4 H2 O; 8 g NaCl; and 1 L distilled water; pH 7) and shaken at 150 rpm and 25 C. overnight. 100 ml LB is inoculated with 1 ml of the preculture and incubated under the same conditions. 10 ml of the last culture are centrifuged (10 min at 10,000 rpm), and the pellet is resuspended in 200 ml saline (0.8% NaCl) giving a concentration of approximately 108 cfu/ml.

For exact determination, a dilution series (100 to 10-8, 20 μl in 180 μl) is prepared in microtiter plate and drops of 10 μl are spotted onto Luria Agar (LB with 1.5% Bacto-Agar, Difco) with an Eppendorf pipette. The cfu are counted after 24 hrs incubation at 28 C.

Antibiotics may be added if required for selection of bacteria: tetracycline 15 μg/ml; kanamycin 50 μg/ml.

b. Cultivation of Rhizoctonia solani

Rhizoctonia solani is grown on Potato Dextrose Agar (PDA, Difco) pH 5.6 in a petri dish. A 300 ml Erlenmeyer flask with 25 g millet and 50 ml distilled water is autoclaved and incubated with one agar plug (5 mm diameter) from a PDA culture of R. solani. After incubation at 20 C. in the dark for 3 weeks, the overgrown millet is air-dried and ground in a Culatti mill (1 mm sieve, 6000 rpm).

c. Cultivation of Pythium aphanidermatum

Pythium aphanidermatum is grown on Malt Agar (Oxoid), pH 5.6 in a petri dish. One agar plug (6 mm diameter) from this culture is transferred to a petri dish with 8 ml oatmeal agar (50 g Oatmeal, 3 ml 1.5% cholestrin in ethanol, and 1 L distilled water) with a slant surface. Two hrs later, 13 ml of sterile distilled water are added, and the plates are incubated for 10 to 14 days in the dark. The mycelium that grows from the agar surface into the water is transferred to a mixer and cut into small pieces. The concentration of oospores is counted in a Thoma chamber and adjusted with distilled water to 2104 /ml.

Example 27 Assays For Biocontrol Activity

Preparation of bacterial cultures: All bacteria cultures are cultured in Luria broth for 2 days at 28 C. Bacterial cells are collected by centrifugation and resuspended in water to 109 or 108 bacterial cells/ml. 10 ml of each suspension is used to drench a pot containing 50 ml soil, resulting in 2108 (high rate, CGA267356 only) or 2107 cells/ml soil (all strains). Preparation of fungal inocula: Rhizoctonia solani is grown on twice-autoclaved millet seed until fully colonized, then air dried for several days. Dried inoculum is ground to a fine powder for use in all assays except the poinsettia assays, in which whole colonized millet seeds are used. A large supply of inoculum is stored at room temperature and used for several months. Pythium aphanidennatum is inoculated on twice-autoclaved millet seed and grown for one week. The colonized millet seed is air dried for 2 hours, then used immediately. Pythium-infested millet seed is prepared weekly.

a. Pathosystem Rhizoctonia solani--cucumber

One cucumber seed is planted per pot containing a standard commercially available peat/bark type potting soil. The bacterial suspension is drenched on each pot and Rhizoctonia inoculum is broadcast over the surface of the soil. Each treatment in an experiment contains 5 sets of 12 plants which are randomized and placed in greenhouse under automatic sprinklers. Each experiment is repeated a minimum of three times. Stand counts are recorded at 1 and 2 weeks after planting and compared to uninfested and untreated healthy controls and infested and untreated diseased controls.

b. Pathosystem Rhizoctonia solani--impatiens

A single hole is drilled in the center of each pot and Rhizoctonia inoculum is broadcast over the surface of the soil and into the hole. One commercially purchased impatiens seedling plug is transplanted into the hole of each pot and bacteria suspension is applied as a drench. Each treatment in an experiment contains 5 sets of 12 plants which are randomized and placed in greenhouse under automatic sprinklers. Each experiment is repeated a minimum of three times. Stand counts are recorded at 1 and 2 weeks.

c. Pathosystem Rhizoctonia solani--poinsettia

The bacterial suspension is drenched on strips of ten Oasis rooting cubes (the cell suspensions were adjusted so that each 50 ml cube was drenched with 40 ml of suspension), resulting in 2108 or 2107 cells/ml of cube, and one commercially purchased poinsettia cutting is inserted into each cube in the normal method for rooting. Five Rhizoctonia-infested millet seeds are placed in the middle of the strip (between plants 5 and 6), and the strips are placed in the greenhouse under automatic sprinklers. Each treatment in an experiment contains 4 rooting strips with 10 cuttings each and each experiment is repeated a minimum of three times. Stand counts are recorded at 10 days and 21 days after planting.

d. Pathosystem Pythium aphanidermatum--cucumber

One cucumber seed is planted per pot and the bacterial suspension is drenched on top of each pot. Pythium inoculum is broadcast over the surface of the soil and replicates are randomized and placed in the greenhouse under automatic sprinklers. Each treatment in an experiment contains 5 sets of 12 plants and each experiment is repeated a minimum of three times. Stand counts are recorded at 1 and 2 weeks.

Example 28 Extraction of Antifungal Metabolites

Active antifungal metabolites such as pyrrolnitrin (prn) can be extracted from the growth medium of bacterial strains that produce inhibitory antibiotics. For example, using strain CGA376146, this can be accomplished by extraction of the growth medium with 80% acetone followed by removal of the acetone by evaporation and a second extraction with diethyl ether. The diethyl ether is removed by evaporation and the dried extract is resuspended in a small volume of methanol. Alternately, the antifungal metabolites can be extracted with methanol using conventional methods. Small aliquots of the antibiotic extract applied to small sterile filter paper discs placed on an agar plate will inhibit the growth of Rhizoctonia solani, indicating the presence of the active antibiotic compound.

Example 29 Combination of Biocontrol Strain With Fungicides

The biocontrol strains of the invention are each applied to non-sterile soil as a drench at 2108 cfu/ml soil, while metalaxyl fungicide is either drenched (Ridomil at 0.02, 0.5, or 2 ppm) or coated onto seeds (Apron at 35 g a.i./100 kg seed). Pythium aphanidermatum is introduced as an oospore suspension (1400 spores/ml soil). Rhizoctonia solani is introduced as a pelleted millet powder (5 mg in the center of each pot). After incubation for 19 days in the greenhouse, the hypocotyls of cotton seedlings are rated for disease on an observation scale.

Almost complete control of damping-off may be achieved when one of the biocontrol strains is applied together with Ridomil at 2 ppm. Using Apron instead of Ridomil results in the same level of control. Each of the biocontrol strains alone still gives significant suppression of both pathogens. Metalaxyl fungicide alone, however, fails to control the disease complex. 0.2 ppm Ridomil alone gives approximately 40% suppression of Pythium aphanidennatum. However, the combination of 0.02 ppm Ridomil with one of the biocontrol strains significantly increases the level of control. Thus, the combined application of the biocontrol bacterial strains of the invention with a reduced rate of metalaxyl fungicide achieves almost complete control of the seedling disease complex in cotton caused by Rhizoctonia solani and Pythium aphanidennatum.

Example 30 Antifungal Compositions

Formulations of antifungal compositions containing as the active ingredient the antifungal metabolites that are produced by the biocontrol strains of the invention and that are inhibitory to the growth of Rhizoctonia and Pythium are produced according to Examples 10 and 11 in U.S. Pat. No. 5,348,742. These formulations include emulsifiable concentrates, solutions, granulates, dusts, wettable powders, extruder granulates, coated granulates, and suspension concentrates.

The antifungal compositions may be used to control or inhibit the growth of a plant pathogenic fungus by applying an effective amount of the biocontrol composition to an environment in which the fungus may grow, to a plant or plant part, and/or to seed.

Example 31 Field Trial of Biocontrol Strains

Cultures of the biocontrol strains are stored in 20% glycerol at -80 C. One loop from the stored culture is suspended in 5 ml Luria Broth (LB: 10 g Bacto-Typtone, Difco; 5 g yeast extract, Oxold; 0.25 g MgSO4 H2 O; 8 g NaCl; and 1 L distilled water; pH 7) and shaken at 150 rpm and 25 C. for 24 hrs. 100 ml LB is inoculated with 1 ml of the preculture and incubated under the same conditions. After 16 hrs, the culture is centrifuged for 10 minutes at 10,000 rpm, and the pellet is resuspended in saline (0.8% NaCl) and adjusted to 3109 cfu/ml (OD2). Thus, 100 ml of culture will give approximately 200-300 ml drench of OD2.

A hemocytomerter and/or spectrophotometer is used to adjust the concentration of bacteria in the drench. Otherwise, a standard salt solution of a known OD (e.g., Phillips' Milk of Magnesia TM=Mg(OH)2) can be used to adjust the OD of the drench. If a centrifuge is not available, the whole culture broth has to be applied; a hemocytometer is then used to determine the cfu/ml.

For exact determination, a dilution series (10 to 10-8 ; 20 μin 180 μl) is prepared in a microtiter plate and drops of 10 μl are spotted onto Luria Agar (LB with 1.5% Bacto-Agar, Difco) with an Eppendorf pipette. The cfu are counted after 24 hrs incubation at 28 C.

250 mL of the bacterial suspension per 10' (=1 rep) are drenched onto the covered seeds (200 seeds per rep). A handheld sprayer or watering can free of pesticide residues is used to apply the drench in a narrow band of approximately 1.5 inches width.

Rhizoctonia and Pythium are prepared for inoculation as in Examples 10 and 11 above.

Emergence is recorded at 10 days after planting to assess pre-emergence damping off. Stands are recorded at 21 days and 28 days after planting to assess post-emergence damping-off.

While the present invention has been described with reference to specific embodiments thereof, it will be appreciated that numerous variations, modifications, and embodiments are possible, and accordingly, all such variations, modifications and embodiments are to be regarded as being within the scope of the present invention. Furthermore, all publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are therefore hereby incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

              TABLE 1______________________________________Pyrrolnitrin production by P. fluorescens strain CGA267356 andgenetically modified strains derived from it. Pyrrolnitrin wasisolated from 3 day old cultures of the strains grown in CMMMADmedium by extraction with methanol and quantified by HPLC analysis.Strain           Pyrrolnitrin (mg/liter)______________________________________CGA267356 (MOCG134)            40.0CGA376146 (MONO571)            40.0CGA364473 (MONO517)            45.0CGA375258 (MONO568)            175.0CGA376148 (MONO573)            150.0CGA364476 (MONO520)            50.0CGA375260 (MONO570)            65.0CGA375259 (MONO569)            160.0CGA378584 (MONO591)            70.0CGA364474 (MONO518)            38.0CGA364475 (MONO519)            50.0CGA366259 (MONO524)            72.0CGA376150 (MONO575)            75.0NOA402208 (MONO630)            250.0NOA402210 (MONO632)            120.0NOA402212 (MONO634)            320.0NOA402214 (MONO636)            330.0NOA402216 (MONO638)            360.0NOA409063 (MONO686)            245.0NOA409068 (MONO691)            109.0NOA413174 (MONO706)            63.0NOA413175 (MONO707)            79.0NOA413176 (MONO708)            55.0NOA413177 (MONO709)            160.0NOA413178 (MONO710)            128.0______________________________________

              TABLE 2______________________________________Biocontrol activity of P. fluorescens strain CGA267356 and geneticallymodified strains derived from it. The data presented is the control ofRhizoctonia on three plant types and Pythium on cucumbers only. Alldata is presented relative to the parent strain, CGA267356, appliedat high (H) ( = 100% biocontrol activity) and low (L) ( = 0%biocontrol activity) rates equal to 2  108 and 2 107 cells/gsoil, respectively. All other strains were applied only at the lowrate so that any relative biocontrol activity greater than 0 representsan improvement compared to the parent strain. All data are the mean ofthree experiments. nd = not determined.   Relative Biocontrol Activity   Rhizoctonia         PythiumStrain    Cucumber  Impatiens Poinsettia                                 Cucumber______________________________________CGA267356 (H)     100       100       100     100CGA267356 (L)     0         0         0       0CGA376146 34        67        29      33CGA364473 13        88        43      57CGA375258 87        67        61      32CGA376148 28        68        133     4CGA364476 60        0         75      133CGA375260 102       0         47      83CGA375259 60        33        52      51CGA378584 115       45        54      0CGA267pPhz     53        10        0       50CGA364474 32        25        0       18CGA364475 42        41        5       9CGA366259 66        38        30      12CGA376150 33        35        51      83NOA402208 225       130       nd      0NOA402210 163       80        nd      0NOA402212 125       80        nd      0NOA402214 25        133       nd      0NOA402216 163       110       nd      0NOA409063 400       117       102     ndNOA409068 267       217       nd      ndNOA413174 100       67        nd      ndNOA413175 125       17        nd      ndNOA413176 0         133       nd      ndNOA413177 167       166       nd      ndNOA413178 267       0         nd      nd______________________________________

              TABLE 3______________________________________Genotypes of the different Pseudomonas strains.Strain            Genotype______________________________________CGA267356 (MOCG134)             wild-type strainCGA376146 (MONO571)             CGA321730, pE11aCGA364473 (MONO517)             ATG-gacACGA375258 (MONO568)             pPrnbCGA376148 (MONO573)             CGA321730, pPrnCGA364476 (MONO520)             pLem/GacCGA375260 (MONO570)             gac*3CGA375259 (MONO569)             tac/gacA, pPrnCGA378584 (MONO591)             cPrn, pLem/GacCGA267pPhz (MONO597)             pPhzCGA364474 (MONO518)             lac/gacACGA364475 (MONO519)             tac/prnABCDCGA366259 (MONO524)             tac/prnABCD, pE11CGA376150 (MONO575)             CGA267355, pE11NOA402208 (MONO630)             gac*3, pPrnNOA402210 (MONO632)             res-c, pPrnNOA402212 (MONO634)             gac*3, res-, pPrnNOA402214 (MONO636)             ATG-gacA, res-, pPrnNOA402216 (MONO638)             lac/ATG-gacA, res-, pPrnNOA409063 (MONO686)             pGac*3/PrnNOA409068 (MONO691)             pKT-PrndNOA413174 (MONO706)             res-, pKT-PrnNOA413175 (MONO707)             gac*3, pKT-PrnNOA413176 (MONO708)             gac*3, res-, pKT-PrnNOA413177 (MONO709)             ATG-gacA, res-, pKT-PrnNOA413178 (MONO710)             lac/ATG-gacA, res-, pKT-Prn______________________________________ a Plasmid pRK290 carrying an 11 kb EcoRI fragment with the native gacA gene. b Plasmid pRK290 carrying the prnABCD gene cluster under control of the tac promoter. c 2bexyl-5-propyl-resorcinol nonproducing phenotype from a chromosomal deletion. d Plasmid pKT231 carrying the prnABCD gene cluster under control of the tac promoter.

              TABLE 4______________________________________The following strains were deposited with the Agricultural ResearchService, Patent Culture Collection (NRRL), 1815 North UniversityStreet, Peoria, Illinois 61604, under the Budapest Treaty on theInternational Recognition of the Deposit of Microorganisms for thePurposes of Patent Procedure. All restrictions on the availabilityof the deposited strains will be irrevocably removed upon thegranting of a patent.Strain      Accession Number                      Deposit Date______________________________________CGA376146   NRRL B-21811   September 5, 1997CGA364473   NRRL B-21812   September 5, 1997CGA375258   NRRL B-21813   September 5, 1997CGA376148   NRRL B-21814   September 5, 1997CGA364476   NRRL B-21815   September 5, 1997CGA375260   NRRL B-21816   September 5, 1997CGA375259   NRRL B-21817   September 5, 1997CGA378584   NRRL B-21818   September 5, 1997CGA267pPhz  NRRL B-21819   September 5, 1997CGA364474   NRRL B-21887   November 20, 1997CGA364475   NRRL B-21888   November 20, 1997CGA366259   NRRL B-21889   November 20, 1997CGA376150   NRRL B-21890   November 20, 1997NOA402208   NRRL B-21891   November 20, 1997NOA402210   NRRL B-21901   November 20, 1997NOA402212   NRRL B-21892   November 20, 1997NOA402214   NRRL B-21893   November 20, 1997NOA402216   NRRL B-21894   November 20, 1997NOA409063   NRRL B-21902   November 20, 1997NOA409068   NRRL B-21895   November 20, 1997NOA413174   NRRL B-21896   November 20, 1997NOA413175   NRRL B-21897   November 20, 1997NOA413176   NRRL B-21898   November 20, 1997NOA413177   NRRL B-21899   November 20, 1997NOA413178   NRRL B-21900   November 20, 1997______________________________________

__________________________________________________________________________#             SEQUENCE LISTING- (1) GENERAL INFORMATION:-    (iii) NUMBER OF SEQUENCES: 11- (2) INFORMATION FOR SEQ ID NO:1:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 10763 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#fluorescens) ORGANISM: Pseudomonas     (B) STRAIN: CGA267356 ( - #aka MOCG134 and aka BL915)-    (vii) IMMEDIATE SOURCE:     (B) CLONE: Plasmid pE11-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 210..1688#/product= "methyltransferase"N:#"Coding sequence for methyltransferase has#and            homology - # to the cheR and frzF genes from E. coli           Myxococc - #us xanthus, respectively."-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1906..3633#/product= "sensor kinase"ATION:#"Coding sequence for sensor kinase has homology           to th - #e rcsC, frzE, and bvgS genes of E. coli,           M. Xa - #nthus, and Borditella pertussis, respectively."-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #RNA#(4616..4691) LOCATION: complement#/product= "tRNA"ER INFORMATION:#"(complementary DNA strand) Homology to glyW from           E. Co - #li."-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature#(4731..5318) LOCATION: complement#/product=(D) OTHER INFORMATION:          "CDP-diac - #ylglycerol-glycerol-3-phosphate-3-phosph          atidyltrans. - #"#"Coding sequence for          CDP-diacylgl - #ycerol-glycerol-3-phosphate-3-          phosphatidyl - #transfere se has homology to pgsA."-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature#(5574..7397) LOCATION: complement#/product= "UVR exonuclease subunit          C"#hasding sequence for UVR exonuclease subunit C#to uvrC."     homology-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature#(7400..8041) LOCATION: complement#/function= "responseNFORMATION:          regulator/tr - #anscription activator"          /product=- # "gacA (aka gafA)"#"Coding sequence for gacA (aka gafA) has homolo - #gy           to th - #e uvrY and gacA genes of E. coli and Ps.           fluoresc - #ens, respectively."#ID NO:1: (xi) SEQUENCE DESCRIPTION: SEQ- GAATTCGATG ACATGCCGCG CGCCGGCATC GACACGCAAA TGGTCGACCT GG - #TGCTGCCG  60- GTGGTCGAAA TGCCGCAGAA GCTGCTGGAG CTGTGGCGCA ACTCTCAGCT CA - #TCACCCTG 120- CCGACCGCCA ACGATCCGCA AATCAAGGTC TCGGCGCCGG TGTCCAAACG CG - #ATGCCGCG 180- GCGGCGAACA GCAGCTGCAA GACATCCTGA TGCTGTTGCG CACCGGCACC GG - #CCATGACT 240- TCAAGCATTA CAAGCGCGCC ACGGTGCTGC GGCGGATCGA GCGCCCGCTG CA - #GGTCACCG 300- CCCAGCCGGA CCTCGCCGCC TATCACGATT ACCTGCAGAT GCACCCTGAA GA - #AACCAAGG 360- CGCTGCTGGG CGACATGCTG ATCGGCGTGA CCAATTTCTT TCGCGACCGC GA - #GGCCTTCG 420- AAGCCCTGGA GCGCAATGTC ATTCCTGCCC TGGTGAAGTC CTTGCAGGAC AG - #CCAACCGC 480- ACCGTGAAGA CGTGCGCATC TGGTCCGCCG GCTGCTCCAC GGGTGAAGAG GC - #CTATAGCC 540- TGGCAATCGT CGCCAGCGAG CAGATGGCCC TGGAGGCCTG CAACGCCAAG CT - #GCAGGTAT 600- TCGCGACCGA TATCGACGAT CGTGCCATCG CCCAGGGACG CAAGGGGGTC TA - #TCCCGAAG 660- CGATCGTTAC CGATGTGCCT CCGCAGCGCA TGCGCCAGTA CTTTTCCCGG GA - #AAACCAGC 720- ATTACCGGGT GCGCAAGGAG ATTCGCGAAA AGGTGCTGTT CGCCAAGCAC AG - #CCTGCTGG 780- CGGATCCGCC ATTTTCGCAG ATCGACTTGA TCGTCTGCCG TAACCTGCTG AT - #CTACCTGG 840- ACCGCGACGT GCAACGGGAG ATCCTGCAGA TGTTCCACTT CGCCCTGCGT CC - #TGGAGGCT 900- ACCTGTTCCT CGGTTCCTCC GAATCCGCGG ACGGCTGCCA GGATCTGTTC GT - #GCCGGTCG 960- ACAAGCGCAA CCGCATTTTC CGGGTACGGC CCAACTCGGC CACGGTTCGC CG - #CGCGCCCA1020- CCATGCCGCG ACGGCGTACA TGCGCACCAT CGGCAGCCCC CACCCCGTGG AA - #ACCAAGTG1080- TCTCGCGCAA AACCTCGTTC GCCGACATCC ACCTTCGCGC CCTGGAAAAG TG - #CGCGCCGC1140- CGAGCATGAT CGTCGATGCC AACGCCGACA TCCTGCACAT GAGCGAAGGC GC - #CGGCCGGT1200- TCCTGCGCTA TGTCGCGGGG GAAATCACCC GCAACCTGCT GACCCTGATC CA - #GCCCGAGC1260- TGCGCCTTGA ACTGCGCACC ACGCTGTTCC AGGTGCAACA GTCCGGTGTT GC - #GGTGACCG1320- CCGCCGGGTG CGCATCGAGC GGGAAAAGAA GCCTTGTTTC ATCGACCTCA CA - #GCCCGCCC1380- CTTCAAGGAC GAGGAAACCG ACAACGAATA TGTGCTGGTG GTGTTCGAGG AG - #ACCGAGGC1440- CGACCCACGG GAGCTGCGCG AGACCAGCGC CAGCCAGACG GAAAACCAGA TG - #CTGGCCAA1500- CCTCGAGCGG GAGTTGCAGC GGACCAAATT GCACCTGCAG GACACCATCG AG - #CAATCGGA1560- AGTCTCCAGC GAGGAGCTCA AGGCGTCGAA CGAAGAAATG CAGGCGCTCA AT - #GAAGAGCT1620- GCGCTCGGCC ACCGAAGAGC TGGAAACCAG CAAGGAAGAG TTGCAGTCGA TC - #AATGAAGA1680- GCTGCTGACG GTCAATTACG AGCTGAAAAC CAAGGTCGAG GAAACCGACA AG - #ATCAACGA1740- CTACCTGACC AACCTGATCG CCTCCACCGA CATCGCCACG GTGTTCGTCG AC - #CGCAACAT1800- GCGCATCCGC TGGTTCACCC CGCGCGCCAC CGACATTTTC AGCATGCTGC CG - #GTGGACAC1860- CGACGCTCAT TACTGGACAT CACCCACCGC CTGAACTACC CGGAAATGGC CG - #AGGACGCC1920- GCGACCGTGT TCGAGTCGTT GAGCATGATC GAGCGTGAAG TCAACAGCGA CG - #ATCAGCGC1980- TGGTACATCG CACGCCTGTT GCCCTATCGC TCCAGCGAAG ACCATATCGA CG - #GCACCGTG2040- CTGACCTTCA TCGATATCAC CAAGCGCCGG CTGGCCGAGG AGGAACTGCG CC - #TGGGCGAA2100- GAACGCATGC GCCTGGTCGC CGAAAGCACC CATGATTTCG CCATCATCAT CC - #TCGACAAC2160- CAGGGCCTCA TCACCGACTG GAACACCGGG GCGCAACTGA TCTTCGGCTA TA - #CCAAGGAC2220- GAAGTGCTGG GCGCCTATTA CGACCTGATT TTCGCGCCTG AGGACCGCGC CG - #GCGGCGTG2280- CCGGAAAGCG AGCTGCTCAC CGCCCGCGAA CACGGCCGCA GCGACGATGA AC - #GCTGGCAT2340- ATACGCAAGG ACGGCGAGCG CTTTTTCTGC AGCGGCGAAG TCACGCGGCT CA - #AGGGTGAC2400- AGCCTGCAAG GCTACGTGAA AATAGCCCGC GACCTGACGG GCCACAAACG CA - #TGCAGGAC2460- GAGCAGAACC AGAAGCTGAT GGAGACCCAG ACCCACAGCC ACCTCAAGGA TG - #AGTTTTTC2520- GCGGTGATGT CCCATGAACT CAAGCATCCG CTCAACCTGA TCCAGCTCAA CG - #CCGAGTTG2580- CTGCGTCGCC TGCCGACGAC CAAGGCGGCC GCCCCTGCCC TCAAGGCGGT CA - #ATACCATT2640- TGCGAGGCTG TCTCCAGCCA GGCGCGGATC ATCGACGACC TGCTGGATGT GC - #GGCGTTTG2700- CGCACCGGCA AGCTCAAGCT GAAGAAACAG CCGGTGGATC TTGGCCGGAT CC - #TGCAGGAC2760- ATCCATACCG TGGTGCTCAG CGAAGGGCAT CGCTGCCAGG TGACGCTGCA AG - #TGCCGTTG2820- CCACCGCAAC CGCCGTTAAT GATCGATGCC GATGCGACGC GGCTGGAGCA GG - #TGATCTGG2880- AACCTGGTGA ACAACGCCCT GAAATTCACC CCGGCCAATG GCTTGGTCCA GT - #TGATCGCC2940- CAGCGGGTCG AGGATAAGGC GCACGTGGAT GTCATCGACA GCGGCGTGGG CC - #TGGCCGAG3000- GAAGACCAGA ACAAGGTGTT CGACCTTTTC GGCCAGGCGG CCAACCAGCA CG - #GCACTCAT3060- CAACGCGACG GGCTGGGCAT CGGCCTGTCA CTGGTGCGCC AGCTGGTGGA AG - #CCCACGGC3120- GGCTCGGTCA GCGTGCAGTC GAAGGGGCTG GGCCAGGGAT GCACCTTTAC CG - #TGCTCTTG3180- CCCCTGAGCC ACCCCAACGA CAGCGCTCCC AAACAGCCCG CGTCGCGGGG TG - #TCGAACGC3240- CTTGCCGGCA TCAAGGTGCT GCTGGTGGAC GACTCGCGGG AAGTCATGGA AG - #TCCTGCAA3300- CTGCTGCTGG AGATGGAGGG CGCGCAAGTC GAGGCCTTCC ACGACCCGCT GC - #AGGCCTTG3360- GGCAATGCCA GGAACAACAG TTACGACCTG ATCATTTCAG ACATCGGCAT GC - #CGATTATG3420- AACGGCTACG AACTGATGCA GAACCTGCGC CAGATCGCTC ACCTGCACCA TA - #CGCCAGCG3480- ATTGCGCTGA CCGGTTACGG CGCCAGCAGC GACCAGAAGA AGTCCCAGCA TG - #CGGGATTC3540- GATCGGCATG TGAGCAAACC CGTGGCTCAG GACCCGCTGA TCGACCTGAT CA - #GGGAGCTG3600- TGCAGCCAGG GCTTGCGCTC GGCTGAGCAC TGATGGTCTA GACCCGGCGA AC - #CCACCTCG3660- TCGGCCTTGA GCGCGGCGAG CGCCATTGCC TGCTGGGCAG CTATTCACGC TT - #GCGGATCG3720- TCGCGCCTGC GGGCCACCGC CTCTTTGATG GCTTGCTCAT AGGCGGCGTT GG - #CCTGGTCC3780- TTGAGCTTGA GCCAATCGTC CCAATCGATC ACGCCGTTGC GCAGCAACTC CT - #CGGCCGCG3840- CTTAACAGCG CCTGATGCCA GGCGTCCGGC GAGCCGGAAC GGTAGTCACG GT - #CTTCCAGC3900- AGGCCTTGCC AGGCGTCCAG TTCCGGTGTC TTGCGTTCAT TGACCATGGC AG - #CCACGGCC3960- TTTGTTCATT GCCGATAAAT CGGCGAGTGG GTGGTGGGTT TCTCGGATAT GC - #GCCCTGTC4020- CTGCTCGAGA ACGGCCAGGC CGGGACATTG CTCAACGGTC AGCGACCGGA TG - #GAGCTCGA4080- GCGGCATGCC ATCGACCAGC GTCAAGGTCA GGTTCTCGAT GGTGCCGGCG AT - #CCGGTCCT4140- TGAATACCGG TTCGCCGTCC GGATCCAACT CATCGTAGAA AAAGCGCGTG CC - #TTCGAGCC4200- AGCCAATGGT CGTTTGCAGG TCCGGCCCCA GGTAATACTT GCCGTCAAGG AA - #AAACCCGG4260- TAAAGGGCTC CACCCGCTCG CGATTCTCAA TGACATAACG TATTCCAGCG TG - #CATACCTG4320- TCGATTTATC GAGCATGGCG TCGATCTCCC AGCAGATGAA TCCGGTAGAC CG - #CGTGGCTT4380- TTTCACTGTT CCTTTTGATT GCCCGCCCGA CGCTGGCGAG CCTTGCTCGC GC - #GTCCTGGC4440- CGCATTGCGC GGCGAATGGG CGACGTCGAA TCCGATCTGC AAGTGCCCAG CT - #AGCGGCCC4500- GGCCACGGCA ATACGGGCTT CAGGTACGGC TTAGAAAGAA GAATGACGAT TG - #GCTCGACA4560- TATTTTTTGG CGCAAAAAAA AATGGACCTC TTTTCAGAGG TCCATTTTTA AT - #ATTTGGAG4620- CGGGAAACGA GACTCGAACT CGCGACCCCG ACCTTGGCAA GGTCGTGCTC TA - #CCAACTGA4680- GCTATTCCCG CGTCTTGGTG GTGTGCATTT TATAGAAATT CGAAACTGCG TC - #AACCCCTT4740- GATTCAAAAA GTTTTATTTC TTTTCTACCA TCGGTCTTCA GGTGCGGCCA GG - #CAGCGCGC4800- AGGTACTGCA ACATCGACCA CAGGGTCAGC CCTCCGGCGA TCAGCAGGAA GG - #CATAACCC4860- AGCAGCACCC AGAAGGTGAA GGCCGGCGGA TTGGCCAGCA GGATCACCAG CG - #CCAGCATC4920- TGCGCGGCAG TTTTCCGATT TGCCCATGTT GGACACCGGC CACCTGGGCG CG - #TGCGCCCG4980- AGCTCGGCCA TCCACTCGCG AAGGGCGGAC ACCACGATTT CACGCCCGAT GA - #TCACCGCT5040- GCCGGCAGGG TCAGCCACAG GTTGCCGTGC TCTTGCACCA GCAGCACCAG GG - #CCACCGCC5100- ACCATCAACT TGTCGGCCAC CGGATCGAGG AAGGCCCCGA ACGGCGTGCT CT - #GCTCCAGA5160- CGCCGCGCCA GGTAGCCATC AAGCCAGTCG GTGGCCGCGG CGAACGCAAA GA - #CGGAACTG5220- GCGGCCATGT AGCTCCAGTT GTAAGGCAGG TAAAACAGCA AAATGAAGAT CG - #GGATGAGC5280- AGAACGCGTA GAACGGTGAT CAGATTAGGG ATATTCATCG GCACAACTGG CT - #ACGAGGTG5340- AGTGGCAATC TACTCGGAAA AGACAGCAGA TGAGGTAGCA CGGCCATTCT AC - #GGGCTTCT5400- GCCACAGCGT GTCTAACACT GTTCCAAGAC TTCGGGCCGC TCGAAAGAGC AA - #CTTCAGAA5460- GGTCTACACG CGCAAAATAA GACATTCAGT TCTTCTGTAA GTACCGTGTA GA - #TCGGGATC5520- TATCAGCGGT GCCCCGCCAA AAAGGAAGCC TTGAAGCTTC CTTGAGCGCT CC - #CCTACTCG5580- CTATGCAAGT TCGCATAAAT CAGCTCAGCG AGCTTTTTAC TGATCCCCGG CG - #CTTTGGCG5640- ATCTCCTCAA TGCTGGCGCG AGACAGTTCC TGCAACCCAC CAAAGTGTTT CA - #ACAGGTCG5700- CGGCGGCGCT TGGGGCCGAC GCCGGCCACG TCTTCGAGGG TCGAAGTGCG GC - #GGGTCTTT5760- CCGCGACGGG CGCGGTGGCC AGTGATGGCG AAACGGTGAG CCTCGTCGCG GA - #TCTGCTGG5820- ATCAGGTGCA GCGCCGGCGA GTCGCCCTTG AGGGTGAACT CATGGGCGGC AT - #CGTTGAGG5880- TAGAGGGTCT CGAAACCGGT CTTGCGCGTC GCACCCTTGG CCACACCCAG CA - #GGATCAGG5940- TCAGGCACCG CCAACTCGTT GAGCACGTCG CGGGCCATGG ACAGCTGGCC CT - #TGCCGCCG6000- TCCACCAGCA GGATGTCCGG CAACTTGCCC TCGCCGTCCT TGAGTTTGCT GA - #AGCGTCGT6060- GTCAGGGCCT GGTGCATCGC CGCATAGTCA TCGCCGGCGG TGACGCCTTC GA - #TGTTGTAG6120- CGCCGATAGT CGGACTTCAG CGGCCCTTCC GGACCGAACA CCACGCAGGA CG - #CCACGGTC6180- GCCTCGCCGC TGGAGTGGCT GATGTCGTAG CACTCCAGGC GTTGCGGTGG CT - #CGTCCAGG6240- TTCAGCACTT CGGCCAGGGC CTCGAAACGC GCCGCCACAT GCTGCCGGTT GG - #CCAGGCGC6300- GCACTCAGCG CCTGTTCGGC GTTGGTCACT GCCAATTGCT GCCAGCGCGC CC - #GCGTACCG6360- CGCACCCGGT GGCTGATGCT CAGCTCGCGG CCACGCAGCT CCTGGATCGC CG - #CGATCAGG6420- GCCGGGAAAT CCTCATGGAC CACGTTGACG ATCAGCTCGC TGGGCAGGTC GC - #GCTCCGGG6480- CTGCTGAGAA AGTACTGGCC GAGGAAGGCC GACATGACTT CGGCCACCTC TT - #CCTCGATG6540- CCCACCTGGG GAAAGAAGTT CTTGCTGCCC AGCACCCGCC CGCCCCGCAC GC - #TGATCAGG6600- TGCACACAGG CGCCGCCCGG GTTGACGAAG GCCGCGACCA CGTCGACGTC GC - #CACTGCCG6660- CCTTCCATGC TCTGCTGGTC CTGGACCCGT CGCAGCAGGG AAATCTGGTC GC - #GCAGCTCA6720- GCGGCCTTTT CGAAGTCCAG GGTGCTGGCC GCCTGCTCCA TGCCGGCCGA CA - #GTTCGTCG6780- GTCAGGGCAT TGCTGCGGCC TTCGAGGAAC ATCACCGAGT GGCGCACATC CT - #CGGCGTAC6840- ACCTCGGCCT CCACCAGGCC GACGCACGGC GCCTTGCAGC GCTTGATCTG AT - #ATTGCAGA6900- CATGGCCGGG TGCGGTTCTT GTAGTAGCTG TCCTCGCACT GGCGGACCAT GA - #AGGTCTTT6960- TGCAGCAGGC TGAGGCTCTC GCGAATGGCC CCGGCGCTGG GGTACGGGCC GA - #AATACTTG7020- CCCTTCTGCT TCTTCGCCCC ACGATGGATG CTGAAACGCG GAAACTCGCC GT - #CCGAGAGA7080- AACACATAGG GATAGGACTT ATCGTCGCGC AGCAGGATGT TGTACGGCGG CC - #GCCATTCC7140- TTGATCAGCG TCTGCTCGAG CAGCAGGGCT TCGGTCTCGT TGGCGGTGAT GG - #TGGTTTCG7200- ATCTGCGCGA TGCGCCCCAC CAGGGCAGCG GTCTTGGGCG CCAGGCCGGT CT - #TGCGAAAG7260- TAGCTGGCCA GGCGGCTCTT CAGGTTCTTG GCTTTACCGA CGTACAGCAG AC - #GCGTATCG7320- CTGTCGAACA TGCGATACAC GCCAGGACGG CCACTGCAGG TGGAAAGAAA AG - #CACTGGGA7380- TCAAACGGGT CGGTCATTGT CAGGCACTGG CATCGACCAT GCCGTGGCGA AC - #CGCCAGCA7440- ATGTCAGTTC AACATCGCTG CTGATCGAGA GCTTTTCGAA GATGCGGTAA CG - #GTAGGTAT7500- TAACGGTTTT CGGAGACAGG CACAGCTTGT CGGAGATGAT CTGCACTTTC TG - #GCAGCCGA7560- CAATCATCAG CGCGATCTGG ATTTCCCGCT CGGACAAAGC ATCGAACGGT GA - #ATCACTGG7620- AAGGCTGGAA TGACTTGAAC ACCAACTGCT GGGCAATTTG CGGGCTGATG TA - #ACGCTGGC7680- CGGCAAACAC CAGGCGAATG GCCTGCACCA TTTCATTGAG GCCCGCCCCC TT - #GGTCAGGT7740- AACCCGCCGC GCCGGCTTGC AGCAAGCGGG TCGGGAACGG ATCTTCTTCA CA - #CACGGTGA7800- CGGCCACGAC TTTGATATCC GGGTGACTGC GCAACAATTT GCGCGTGGCT TC - #AAGACCGC7860- CGATCCCGGG CATCTTGACG TCCATGAGGA CCACATCGGG TTTCAACTCC CG - #GGCCTTGA7920- GCAGGGATTC CTCCCCTGAC TCGGCCTGGC CGACCACTTG CAGGCCATCG AT - #GTCAGCCA7980- GCATTCGTGT AATACCTGTA CGAACGAGAT CATGGTCATC GACTACTAGC AC - #CCTAATCA8040- AGCAGACACC TCGCGATTTG GGTCTTATAG GTTGCCGGAC ACCTTAGCAA AA - #AAGCAGCG8100- TGCTGACCTA ATGACAAACA CCATATAAAA AGCACTTGTT CATCAGGGGT AT - #CCGGTGGA8160- TGGTTGATGC GCTGCGAACG CCCTGCCCTA AGGCTCTCGG GCGTCCGCCT TT - #CTTTTCAT8220- GAGGCTGGAA ACCGAAAGCT CGGCAAGGGT ATGGGTCAGG TGCCGGATCG CG - #TCCTGATC8280- TTCCTTGTAC AAGGCCCGGA TAACTGACGA GGCTTTTCTC TTCGCTCTGG CT - #GAGATTCT8340- CAGCCCTGGT CGGGGTCCGC CTGCCGGTCA CTATATAAAG GACATCGACC CC - #TTTTGTCG8400- CCACCCGGGA CAAGTAATCC GCCTTGGGCA CACGGTCTCC ACTTTCATAT CT - #GCCTTGGG8460- CATTGGCTTC CACGCCGCCA ACTTCACCAA ATTTTTTCTG CGACAACCCC AG - #GCGTTCCC8520- TTTCCTGTCG TCAACCGCGA ACCGATTCCA CTCATTTGGA TGTATGATCC TT - #TTTTATGC8580- ACCCCTAGGG GTGTTACACC CTTCAAGCAT TGAACAAATT TGAACGGTTT TG - #AACTATGC8640- CCGGTTATCC GCACTGCCGC ACAAGCCAAG GCCTGGCTTG AACATCAAGG TA - #AATCGGTT8700- CAACAGTTCG CTCGTGATCA CGGGGTCGAT CCAGCCACCA CTTATCAGGT AT - #TGGCTGGC8760- CGCAAGAAAG GACGGCGCGG CGAGGCGCAC AAGGTGACCG TATTGCTGGG CA - #TGAAAGAC8820- GGCGTCATCC TGGCCGAACC CGAGGGTCCC GACCAGACGC CCGCCTGATC TT - #CGAATGCC8880- ATCATCCTGC CGGGAAGAAT CAACTGGCGG CTACGCCTCC ACGGCGCTGC TT - #CGCTCCAT8940- CCGCAGAAAA CACTCGTCTT CCCCGACCAC TTTCAGCCCC ATCCGCCCAT AA - #AGCGCCTG9000- CGCCGGATTG TCCTTGAACA CCGTCAGCCG CAGCAGCCCA CGCCGCTCGT CA - #TGCGCCAT9060- CGCACGCACC TGTTCGATGG TCCAGGCCCC GACGCCTTGC CCGCGCGACG CC - #TCGAGCAC9120- ATGCAATTCA CGAATGTACA AAGCCTTGGC ATCGCGACTC AGGCTGACGA AC - #CCCAGCAC9180- CCTGGCGCCC TGGCAGATCA ACAGGTTCTG CCGACCGGCC CAGGCCACAT CG - #AAGGCCTC9240- ATCCAGCCAC AACAGGTCGT GACGAATGTG ATAACCCAGC ATGGTGCTGC GG - #GTCAGGTC9300- GCGGGCGAAC ACCAGATCCT CGTGGCTGCC GGCCGGACGT AGCTGCAGGC CG - #TTCAAGGC9360- GCGTCAACCG GCAATGACTG GCCACTCCAG CGCCCGGCAT TGCGCCTGGC AA - #TCAGCAGT9420- TCGTCGCCTG TACCGGCCGA AGCCATGATC AGCCCGCCGC CGGCGCCCCA GA - #TCGCGCTA9480- CGCCCCGCCG ACACCCAGCC CCCGGTCGGC CCGCCGTGGT TGGCCATCAG CA - #CCAGCATT9540- GCGTGCTCGG CGGCATACCC CTGCAACAAG GCACTGTCCG CGGCATAGCC TG - #TTTCGCCG9600- ATCAAAACGC CAGCGGCATA GATGCCGGCA CCGGAGTGCG CCGCCGCACG CG - #CGTGGCTG9660- GCCTGGGAGA AGTCGGCGCA CACCGCCAGG GCCACCTGGT CTTCGGCGAA CC - #TCAGGTTC9720- GCGCCACCGG TGCCGGGGCT GAATACCCGC TCCTCGCCAG CATGCAGATG CT - #GCTTGCTG9780- TACACCGCCA GCGAACCATC GGCGGCCAGC ACCAGGGCGC CGATCAACAG CG - #GCCCCTCG9840- ACCGACAGGC GGACGGGCAT GCCCACCACC GCTGTTACGC CCCGCTCCCG GG - #CCAGGTCG9900- CGCAACGGTT GCAACAGCGG GCTCTGCGGC AGTATCGCCA GCTCGGCCGC CA - #GCGCGGGC9960- TCATAACCGG TCAGGGACAG CTCGGGAAAT ACCAGCAATT GCACGCCCTG CT - #CCGCCGCG10020- ACGCGGATAA AGGCCTGGTG CCGGGCGATA TTGCCCGGCA GGTCTCCGGC AA - #CGGAAATC10080- GACTGGGCGG CGGCAAGGGT CAGCATGGTC ATGGTTCAAC CTGAATCGGC AT - #TCGGGAGG10140- GCGTGGCGAG TGTGTCATAA AAAACTCAAA GCGCTTCACT CATAGACAGC GA - #CTGAAAAC10200- GCAATAGGAT TTTCTGATTG AACCGCGCCC CCGGCCTCTA GTAAGCTCGG CC - #CACTTCAC10260- GGAGAAACAG CATGTCGTCC CTCACCCTTA CCATGCATCG TCACACTGCC AG - #CGCCGCGC10320- GCTCCGGTGC GGCTGCCTGG GTGAAAAACG CCTGCGCTCC GGCGGGCTTT TA - #TTTTGGGT10380- ATTGGTTTAG CCACTGGCGC GCCTGATACC CAAACGGCGC CCACTTGAAC GG - #GTCGCCTA10440- CCAGAGAAAA TCTCACCCCC GGTCGGCCTC CCGACCGGGG GTTTTGTTTT TC - #TGGGCCGA10500- AGATTTTTAA CCGCGACTTC TTAAGCAACA CACCGAACTT ACCGAGGATT GA - #ACCATGAA10560- CTACGCCACC TATTACCGTT ACGACACTTG CACCACCTGG CGATTTAGCA GC - #CTCCGTTC10620- GGGACAGCCT GCCGCCTCCG ATCGGTCACC TACTGGTGGC AAACATACCT GC - #ACAGCCAA10680- TCCGGCCAAT TGTCGAACAC CCCAGTAGGG CCGCGCGCGG GAAATCACCC GC - #CGCCTGCC10740#             10763TGAA TTC- (2) INFORMATION FOR SEQ ID NO:2:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 642 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#fluorescens) ORGANISM: Pseudomonas     (B) STRAIN: CGA267356 ( - #aka MOCG134 and aka BL915)-     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 1..639#/transl-- except= (pos: 1 .. 3, aa: Met#ID NO:2: (xi) SEQUENCE DESCRIPTION: SEQ- TTG ATT AGG GTG CTA GTA GTC GAT GAC CAT GA - #T CTC GTT CGT ACA GGT  48Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- ATT ACA CGA ATG CTG GCT GAC ATC GAT GGC CT - #G CAA GTG GTC GGC CAG  96Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#             30- GCC GAG TCA GGG GAG GAA TCC CTG CTC AAG GC - #C CGG GAG TTG AAA CCC 144Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- GAT GTG GTC CTC ATG GAC GTC AAG ATG CCC GG - #G ATC GGC GGT CTT GAA 192Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- GCC ACG CGC AAA TTG TTG CGC AGT CAC CCG GA - #T ATC AAA GTC GTG GCC 240Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- GTC ACC GTG TGT GAA GAA GAT CCG TTC CCG AC - #C CGC TTG CTG CAA GCC 288Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- GGC GCG GCG GGT TAC CTG ACC AAG GGG GCG GG - #C CTC AAT GAA ATG GTG 336Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- CAG GCC ATT CGC CTG GTG TTT GCC GGC CAG CG - #T TAC ATC AGC CCG CAA 384Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- ATT GCC CAG CAG TTG GTG TTC AAG TCA TTC CA - #G CCT TCC AGT GAT TCA 432Ile Ala Gln Gln Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- CCG TTC GAT GCT TTG TCC GAG CGG GAA ATC CA - #G ATC GCG CTG ATG ATT 480Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- GTC GGC TGC CAG AAA GTG CAG ATC ATC TCC GA - #C AAG CTG TGC CTG TCT 528Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- CCG AAA ACC GTT AAT ACC TAC CGT TAC CGC AT - #C TTC GAA AAG CTC TCG 576Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- ATC AGC AGC GAT GTT GAA CTG ACA TTG CTG GC - #G GTT CGC CAC GGC ATG 624Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205# 642              CC TGAVal Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:3:-      (i) SEQUENCE CHARACTERISTICS:#acids    (A) LENGTH: 213 amino     (B) TYPE: amino acid     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: protein-           (xi) SEQUENCE DESCRIPTION: - # SEQ ID NO:3:- Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#             30- Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- Ile Ala Gln Gln Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205- Val Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:4:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 642 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#fluorescens) ORGANISM: Pseudomonas     (B) STRAIN: CGA267356 ( - #aka MOCG134 and aka BL915)-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1..3#/note= "TTG initiation codon in          native se - #quence modified to ATG initiation codon."-     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 1..639#ID NO:4: (xi) SEQUENCE DESCRIPTION: SEQ- ATG ATT AGG GTG CTA GTA GTC GAT GAC CAT GA - #T CTC GTT CGT ACA GGT  48Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- ATT ACA CGA ATG CTG GCT GAC ATC GAT GGC CT - #G CAA GTG GTC GGC CAG  96Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#            305- GCC GAG TCA GGG GAG GAA TCC CTG CTC AAG GC - #C CGG GAG TTG AAA CCC 144Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- GAT GTG GTC CTC ATG GAC GTC AAG ATG CCC GG - #G ATC GGC GGT CTT GAA 192Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- GCC ACG CGC AAA TTG TTG CGC AGT CAC CCG GA - #T ATC AAA GTC GTG GCC 240Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- GTC ACC GTG TGT GAA GAA GAT CCG TTC CCG AC - #C CGC TTG CTG CAA GCC 288Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- GGC GCG GCG GGT TAC CTG ACC AAG GGG GCG GG - #C CTC AAT GAA ATG GTG 336Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- CAG GCC ATT CGC CTG GTG TTT GCC GGC CAG CG - #T TAC ATC AGC CCG CAA 384Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- ATT GCC CAG CAG TTG GTG TTC AAG TCA TTC CA - #G CCT TCC AGT GAT TCA 432Ile Ala Gln Gln Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- CCG TTC GAT GCT TTG TCC GAG CGG GAA ATC CA - #G ATC GCG CTG ATG ATT 480Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- GTC GGC TGC CAG AAA GTG CAG ATC ATC TCC GA - #C AAG CTG TGC CTG TCT 528Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- CCG AAA ACC GTT AAT ACC TAC CGT TAC CGC AT - #C TTC GAA AAG CTC TCG 576Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- ATC AGC AGC GAT GTT GAA CTG ACA TTG CTG GC - #G GTT CGC CAC GGC ATG 624Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205# 642              CC TGAVal Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:5:-      (i) SEQUENCE CHARACTERISTICS:#acids    (A) LENGTH: 213 amino     (B) TYPE: amino acid     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: protein-           (xi) SEQUENCE DESCRIPTION: - # SEQ ID NO:5:- Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#             30- Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- Ile Ala Gln Gln Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205- Val Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:6:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 7001 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#fluorescens) ORGANISM: Pseudomonas     (B) STRAIN: CGA267356 ( - #aka MOCG134 and aka BL915)-    (vii) IMMEDIATE SOURCE:     (B) CLONE: pCIB169-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 423..2036#/product= "PrnA"ER INFORMATION:#"ORF1"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 2039..3121#/product= "PrnB"ER INFORMATION:#"ORF2"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 3167..4867#/product= "PrnC"ER INFORMATION:#"ORF3"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 4895..5983#/product= "PrnD"ER INFORMATION:#"ORF4"        /note=#ID NO:6: (xi) SEQUENCE DESCRIPTION: SEQ- GAATTCCGAC AACGCCGAAG AAGCGCGGAA CCGCTGAAAG AGGAGCAGGA AC - #TGGAGCAA  60- ACGCTGTCCC AGGTGATCGA CAGCCTGCCA CTGCGCATCG AGGGCCGATG AA - #CAGCATTG 120- GCAAAAGCTG GCGGTGCGCA GTGCGCGAGT GATCCGATCA TTTTTGATCG GC - #TCGCCTCT 180- TCAAAATCGG CGGTGGATGA AGTCGACGGC GGACTGATCA GGCGCAAAAG AA - #CATGCGCC 240- AAAACCTTCT TTTATAGCGA ATACCTTTGC ACTTCAGAAT GTTAATTCGG AA - #ACGGAATT 300- TGCATCGCTT TTCCGGCAGT CTAGAGTCTC TAACAGCACA TTGATGTGCC TC - #TTGCATGG 360- ATGCACGAAG ACTGGCGGCC TCCCCTCGTC ACAGGCGGCC CGCCTTTGAA AC - #AAGGAGTG 420- TTATGAACAA GCCGATCAAG AATATCGTCA TCGTGGGCGG CGGTACTGCG GG - #CTGGATGG 480- CCGCCTCGTA CCTCGTCCGG GCCCTCCAAC AGCAGGCGAA CATTACGCTC AT - #CGAATCTG 540- CGGCGATCCC TCGGATCGGC GTGGGCGAAG CGACCATCCC AAGTTTGCAG AA - #GGTGTTCT 600- TCGATTTCCT CGGGATACCG GAGCGGGAAT GGATGCCCCA AGTGAACGGC GC - #GTTCAAGG 660- CCGCGATCAA GTTCGTGAAT TGGAGAAAGT CTCCCGACCC CTCGCGCGAC GA - #TCACTTCT 720- ACCATTTGTT CGGCAACGTG CCGAACTGCG ACGGCGTGCC GCTTACCCAC TA - #CTGGCTGC 780- GCAAGCGCGA ACAGGGCTTC CAGCAGCCGA TGGAGTACGC GTGCTACCCG CA - #GCCCGGGG 840- CACTCGACGG CAAGCTGGCA CCGTGCCTGT CCGACGGCAC CCGCCAGATG TC - #CCACGCGT 900- GGCACTTCGA CGCGCACCTG GTGGCCGACT TCTTGAAGCG CTGGGCCGTC GA - #GCGCGGGG 960- TGAACCGCGT GGTCGATGAG GTGGTGGACG TTCGCCTGAA CAACCGCGGC TA - #CATCTCCA1020- ACCTGCTCAC CAAGGAGGGG CGGACGCTGG AGGCGGACCT GTTCATCGAC TG - #CTCCGGCA1080- TGCGGGGGCT CCTGATCAAT CAGGCGCTGA AGGAACCCTT CATCGACATG TC - #CGACTACC1140- TGCTGTGCGA CAGCGCGGTC GCCAGCGCCG TGCCCAACGA CGACGCGCGC GA - #TGGGGTCG1200- AGCCGTACAC CTCCTCGATC GCCATGAACT CGGGATGGAC CTGGAAGATT CC - #GATGCTGG1260- GCCGGTTCGG CAGCGGCTAC GTCTTCTCGA GCCATTTCAC CTCGCGCGAC CA - #GGCCACCG1320- CCGACTTCCT CAAACTCTGG GGCCTCTCGG ACAATCAGCC GCTCAACCAG AT - #CAAGTTCC1380- GGGTCGGGCG CAACAAGCGG GCGTGGGTCA ACAACTGCGT CTCGATCGGG CT - #GTCGTCGT1440- GCTTTCTGGA GCCCCTGGAA TCGACGGGGA TCTACTTCAT CTACGCGGCG CT - #TTACCAGC1500- TCGTGAAGCA CTTCCCCGAC ACCTCGTTCG ACCCGCGGCT GAGCGACGCT TT - #CAACGCCG1560- AGATCGTCCA CATGTTCGAC GACTGCCGGG ATTTCGTCCA AGCGCACTAT TT - #CACCACGT1620- CGCGCGATGA CACGCCGTTC TGGCTCGCGA ACCGGCACGA CCTGCGGCTC TC - #GGACGCCA1680- TCAAAGAGAA GGTTCAGCGC TACAAGGCGG GGCTGCCGCT GACCACCACG TC - #GTTCGACG1740- ATTCCACGTA CTACGAGACC TTCGACTACG AATTCAAGAA TTTCTGGTTG AA - #CGGCAACT1800- ACTACTGCAT CTTTGCCGGC TTGGGCATGC TGCCCGACCG GTCGCTGCCG CT - #GTTGCAGC1860- ACCGACCGGA GTCGATCGAG AAAGCCGAGG CGATGTTCGC CAGCATCCGG CG - #CGAGGCCG1920- AGCGTCTGCG CACCAGCCTG CCGACAAACT ACGACTACCT GCGGTCGCTG CG - #TGACGGCG1980- ACGCGGGGCT GTCGCGCGGC CAGCGTGGGC CGAAGCTCGC AGCGCAGGAA AG - #CCTGTAGT2040- GGAACGCACC TTGGACCGGG TAGGCGTATT CGCGGCCACC CACGCTGCCG TG - #GCGGCCTG2100- CGATCCGCTG CAGGCGCGCG CGCTCGTTCT GCAACTGCCG GGCCTGAACC GT - #AACAAGGA2160- CGTGCCCGGT ATCGTCGGCC TGCTGCGCGA GTTCCTTCCG GTGCGCGGCC TG - #CCCTGCGG2220- CTGGGGTTTC GTCGAAGCCG CCGCCGCGAT GCGGGACATC GGGTTCTTCC TG - #GGGTCGCT2280- CAAGCGCCAC GGACATGAGC CCGCGGAGGT GGTGCCCGGG CTTGAGCCGG TG - #CTGCTCGA2340- CCTGGCACGC GCGACCAACC TGCCGCCGCG CGAGACGCTC CTGCATGTGA CG - #GTCTGGAA2400- CCCCACGGCG GCCGACGCGC AGCGCAGCTA CACCGGGCTG CCCGACGAAG CG - #CACCTGCT2460- CGAGAGCGTG CGCATCTCGA TGGCGGCCCT CGAGGCGGCC ATCGCGTTGA CC - #GTCGAGCT2520- GTTCGATGTG TCCCTGCGGT CGCCCGAGTT CGCGCAAAGG TGCGACGAGC TG - #GAAGCCTA2580- TCTGCAGAAA ATGGTCGAAT CGATCGTCTA CGCGTACCGC TTCATCTCGC CG - #CAGGTCTT2640- CTACGATGAG CTGCGCCCCT TCTACGAACC GATTCGAGTC GGGGGCCAGA GC - #TACCTCGG2700- CCCCGGTGCC GTAGAGATGC CCCTCTTCGT GCTGGAGCAC GTCCTCTGGG GC - #TCGCAATC2760- GGACGACCAA ACTTATCGAG AATTCAAAGA GACGTACCTG CCCTATGTGC TT - #CCCGCGTA2820- CAGGGCGGTC TACGCTCGGT TCTCCGGGGA GCCGGCGCTC ATCGACCGCG CG - #CTCGACGA2880- GGCGCGAGCG GTCGGTACGC GGGACGAGCA CGTCCGGGCT GGGCTGACAG CC - #CTCGAGCG2940- GGTCTTCAAG GTCCTGCTGC GCTTCCGGGC GCCTCACCTC AAATTGGCGG AG - #CGGGCGTA3000- CGAAGTCGGG CAAAGCGGCC CCGAAATCGG CAGCGGGGGG TACGCGCCCA GC - #ATGCTCGG3060- TGAGCTGCTC ACGCTGACGT ATGCCGCGCG GTCCCGCGTC CGCGCCGCGC TC - #GACGAATC3120- CTGATGCGCG CGACCCAGTG TTATCTCACA AGGAGAGTTT GCCCCCATGA CT - #CAGAAGAG3180- CCCCGCGAAC GAACACGATA GCAATCACTT CGACGTAATC ATCCTCGGCT CG - #GGCATGTC3240- CGGCACCCAG ATGGGGGCCA TCTTGGCCAA ACAACAGTTT CGCGTGCTGA TC - #ATCGAGGA3300- GTCGTCGCAC CCGCGGTTCA CGATCGGCGA ATCGTCGATC CCCGAGACGT CT - #CTTATGAA3360- CCGCATCATC GCTGATCGCT ACGGCATTCC GGAGCTCGAC CACATCACGT CG - #TTTTATTC3420- GACGCAACGT TACGTCGCGT CGAGCACGGG CATTAAGCGC AACTTCGGCT TC - #GTGTTCCA3480- CAAGCCCGGC CAGGAGCACG ACCCGAAGGA GTTCACCCAG TGCGTCATTC CC - #GAGCTGCC3540- GTGGGGGCCG GAGAGCCATT ATTACCGGCA AGACGTCGAC GCCTACTTGT TG - #CAAGCCGC3600- CATTAAATAC GGCTGCAAGG TCCACCAGAA AACTACCGTG ACCGAATACC AC - #GCCGATAA3660- AGACGGCGTC GCGGTGACCA CCGCCCAGGG CGAACGGTTC ACCGGCCGGT AC - #ATGATCGA3720- CTGCGGAGGA CCTCGCGCGC CGCTCGCGAC CAAGTTCAAG CTCCGCGAAG AA - #CCGTGTCG3780- CTTCAAGACG CACTCGCGCA GCCTCTACAC GCACATGCTC GGGGTCAAGC CG - #TTCGACGA3840- CATCTTCAAG GTCAAGGGGC AGCGCTGGCG CTGGCACGAG GGGACCTTGC AC - #CACATGTT3900- CGAGGGCGGC TGGCTCTGGG TGATTCCGTT CAACAACCAC CCGCGGTCGA CC - #AACAACCT3960- GGTGAGCGTC GGCCTGCAGC TCGACCCGCG TGTCTACCCG AAAACCGACA TC - #TCCGCACA4020- GCAGGAATTC GATGAGTTCC TCGCGCGGTT CCCGAGCATC GGGGCTCAGT TC - #CGGGACGC4080- CGTGCCGGTG CGCGACTGGG TCAAGACCGA CCGCCTGCAA TTCTCGTCGA AC - #GCCTGCGT4140- CGGCGACCGC TACTGCCTGA TGCTGCACGC GAACGGCTTC ATCGACCCGC TC - #TTCTCCCG4200- GGGGCTGGAA AACACCGCGG TGACCATCCA CGCGCTCGCG GCGCGCCTCA TC - #AAGGCGCT4260- GCGCGACGAC GACTTCTCCC CCGAGCGCTT CGAGTACATC GAGCGCCTGC AG - #CAAAAGCT4320- TTTGGACCAC AACGACGACT TCGTCAGCTG CTGCTACACG GCGTTCTCGG AC - #TTCCGCCT4380- ATGGGACGCG TTCCACAGGC TGTGGGCGGT CGGCACCATC CTCGGGCAGT TC - #CGGCTCGT4440- GCAGGCCCAC GCGAGGTTCC GCGCGTCGCG CAACGAGGGC GACCTCGATC AC - #CTCGACAA4500- CGACCCTCCG TATCTCGGAT ACCTGTGCGC GGACATGGAG GAGTACTACC AG - #TTGTTCAA4560- CGACGCCAAA GCCGAGGTCG AGGCCGTGAG TGCCGGGCGC AAGCCGGCCG AT - #GAGGCCGC4620- GGCGCGGATT CACGCCCTCA TTGACGAACG AGACTTCGCC AAGCCGATGT TC - #GGCTTCGG4680- GTACTGCATC ACCGGGGACA AGCCGCAGCT CAACAACTCG AAGTACAGCC TG - #CTGCCGGC4740- GATGCGGCTG ATGTACTGGA CGCAAACCCG CGCGCCGGCA GAGGTGAAAA AG - #TACTTCGA4800- CTACAACCCG ATGTTCGCGC TGCTCAAGGC GTACATCACG ACCCGCATCG GC - #CTGGCGCT4860- GAAGAAGTAG CCGCTCGACG ACGACATAAA AACGATGAAC GACATTCAAT TG - #GATCAAGC4920- GAGCGTCAAG AAGCGTCCCT CGGGCGCGTA CGACGCAACC ACGCGCCTGG CC - #GCGAGCTG4980- GTACGTCGCG ATGCGCTCCA ACGAGCTCAA GGACAAGCCG ACCGAGTTGA CG - #CTCTTCGG5040- CCGTCCGTGC GTGGCGTGGC GCGGAGCCAC GGGGCGGGCC GTGGTGATGG AC - #CGCCACTG5100- CTCGCACCTG GGCGCGAACC TGGCTGACGG GCGGATCAAG GACGGGTGCA TC - #CAGTGCCC5160- GTTTCACCAC TGGCGGTACG ACGAACAGGG CCAGTGCGTT CACATCCCCG GC - #CATAACCA5220- GGCGGTGCGC CAGCTGGAGC CGGTGCCGCG CGGGGCGCGT CAGCCGACGT TG - #GTCACCGC5280- CGAGCGATAC GGCTACGTGT GGGTCTGGTA CGGCTCCCCG CTGCCGCTGC AC - #CCGCTGCC5340- CGAAATCTCC GCGGCCGATG TCGACAACGG CGACTTTATG CACCTGCACT TC - #GCGTTCGA5400- GACGACCACG GCGGTCTTGC GGATCGTCGA GAACTTCTAC GACGCGCAGC AC - #GCAACCCC5460- GGTGCACGCA CTCCCGATCT CGGCCTTCGA ACTCAAGCTC TTCGACGATT GG - #CGCCAGTG5520- GCCGGAGGTT GAGTCGCTGG CCCTGGCGGG CGCGTGGTTC GGTGCCGGGA TC - #GACTTCAC5580- CGTGGACCGG TACTTCGGCC CCCTCGGCAT GCTGTCACGC GCGCTCGGCC TG - #AACATGTC5640- GCAGATGAAC CTGCACTTCG ATGGCTACCC CGGCGGGTGC GTCATGACCG TC - #GCCCTGGA5700- CGGAGACGTC AAATACAAGC TGCTCCAGTG TGTGACGCCG GTGAGCGAAG GC - #AAGAACGT5760- CATGCACATG CTCATCTCGA TCAAGAAGGT GGGCGGCATC CTGCGCCGCG CG - #ACCGACTT5820- CGTGCTGTTC GGGCTGCAGA CCAGGCAGGC CGCGGGGTAC GACGTCAAAA TC - #TGGAACGG5880- AATGAAGCCG GACGGCGGCG GCGCGTACAG CAAGTACGAC AAGCTCGTGC TC - #AAGTACCG5940- GGCGTTCTAT CGAGGCTGGG TCGACCGCGT CGCAAGTGAG CGGTGATGCG TG - #AAGCCGAG6000- CCGCTCTCGA CCGCGTCGCT GCGCCAGGCG CTCGCGAACC TGGCGAGCGG CG - #TGACGATC6060- ACGGCCTACG GCGCGCCGGG CCCGCTTGGG CTCGCGGCCA CCAGCTTCGT GT - #CGGAGTCG6120- CTCTTTGCGA GGTATTCATG ACTATCTGGC TGTTGCAACT CGTGCTGGTG AT - #CGCGCTCT6180- GCAACGTCTG CGGCCGCATT GCCGAACGGC TCGGCCAGTG CGCGGTCATC GG - #CGAGATCG6240- CGGCCGGTTT GCTGTTGGGG CCGTCGCTGT TCGGCGTGAT CGCACCGAGT TT - #CTACGACC6300- TGTTGTTCGG CCCCCAGGTG CTGTCAGCGA TGGCGCAAGT CAGCGAAGTC GG - #CCTGGTAC6360- TGCTGATGTT CCAGGTCGGC CTGCATATGG AGTTGGGCGA GACGCTGCGC GA - #CAAGCGCT6420- GGCGCATGCC CGTCGCGATC GCAGCGGGCG GGCTCGTCGC ACCGGCCGCG AT - #CGGCATGA6480- TCGTCGCCAT CGTTTCGAAA GGCACGCTCG CCAGCGACGC GCCGGCGCTG CC - #CTATGTGC6540- TCTTCTGCGG TGTCGCACTT GCGGTATCGG CGGTGCCGGT GATGGCGCGC AT - #CATCGACG6600- ACCTGGAGCT CAGCGCCATG GTGGGCGCGC GGCACGCAAT GTCTGCCGCG AT - #GCTGACGG6660- ATGCGCTCGG ATGGATGCTG CTTGCAACGA TTGCCTCGCT ATCGAGCGGG CC - #CGGCTGGG6720- CATTTGCGCG CATGCTCGTC AGCCTGCTCG CGTATCTGGT GCTGTGCGCG CT - #GCTGGTGC6780- GCTTCGTGGT TCGACCGACC CTTGCGCGGC TCGCGTCGAC CGCGCATGCG AC - #GCGCGACC6840- GCTTGGCCGT GTTGTTCTGC TTCGTAATGT TGTCGGCACT CGCGACGTCG CT - #GATCGGAT6900- TCCATAGCGC TTTTGGCGCA CTTGCCGCGG CGCTGTTCGT GCGCCGGGTG CC - #CGGCGTCG6960# 7001             CAAC GTCGAAGGTT TCGTCAAGCT T- (2) INFORMATION FOR SEQ ID NO:7:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 1097 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (vii) IMMEDIATE SOURCE:     (B) CLONE: pKK223-3-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1#/note= "BssHII site"NFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 7#/note= "BglII site"INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 265#/note= "EcoRI site"INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 270#/note= "SmaI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 275#/note= "BamHI site"INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 281#/note= "SalI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 287#/note= "PstI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 293#/note= "XbaI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 299#/note= "XhoI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 305#/note= "KpnI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 311#/note= "NotI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 319#/note= "HindIII site"FORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1086#/note= "BglI site" INFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1092#/note= "BssHII site"NFORMATION:-     (ix) FEATURE:     (A) NAME/KEY: promoter     (B) LOCATION: 185..264#/standard-- name= "tac"ON:-     (ix) FEATURE:     (A) NAME/KEY: terminator     (B) LOCATION: 327..752#/standard-- name= "rrnB"N:#ID NO:7: (xi) SEQUENCE DESCRIPTION: SEQ- GCGCGCAGAT CTGGGCTTAT CGACTGCACG GTGCACCAAT GCTTCTGGCG TC - #AGGCAGCC  60- ATCGGAAGCT GTGGTATGGC TGTGCAGGTC GTAAATCACT GCATAATTCG TG - #TCGCTCAA 120- GGCGCACTCC CGTTCTGGAT AATGTTTTTT GCGCCGACAT CATAACGGTT CT - #GGCAAATA 180- TTCTGAAATG AGCTGTTGAC AATTAATCAT CGGCTCGTAT AATGTGTGGA AT - #TGTGAGCG 240- GATAACAATT TCACACAGGA AACAGAATTC CCGGGGATCC GTCGACCTGC AG - #TCTAGACT 300- CGAGGGTACC GCGGCCGCAA GCTTGGCTGT TTTGGCGGAT GAGAGAAGAT TT - #TCAGCCTG 360- ATACAGATTA AATCAGAACG CAGAAGCGGT CTGATAAAAC AGAATTTGCC TG - #GCGGCAGT 420- AGCGCGGTGG TCCCACCTGA CCCCATGCCG AACTCAGAAG TGAAACGCCG TA - #GCGCCGAT 480- GGTAGTGTGG GGTCTCCCCA TGCGAGAGTA GGGAACTGCC AGGCATCAAA TA - #AAACGAAA 540- GGCTCAGTCG AAAGACTGGG CCTTTCGTTT TATCTGTTGT TTGTCGGTGA AC - #GCTCTCCT 600- GAGTAGGACA AATCCGCCGG GAGCGGATTT GAACGTTGCG AAGCAACGGC CC - #GGAGGGTG 660- GCGGGCAGGA CGCCCGCCAT AAACTGCCAG GCATCAAATT AAGCAGAAGG CC - #ATCCTGAC 720- GGATGGCCTT TTTGCGTTTC TACAAACTCT TTTGTTTATT TTTCTAAATA CA - #TTCAAATA 780- TGTATCCGCT CATGAGACAA TAACCCTGAT AAATGCTTCA ATAATATTGA AA - #AAGGAAGA 840- GTATGAGTAT TCAACATTTC CGTGTCGCCC TTATTCCCTT TTTTGCGGCA TT - #TTGCCTTC 900- CTGTTTTTGC TCACCCAGAA ACGCTGGTGA AAGTAAAAGA TGCTGAAGAT CA - #GTTGGGTG 960- CACGAGTGGG TTACATCGAA CTGGATCTCA ACAGCGGTAA GATCCTTGAG AG - #TTTTCGCC1020- CCGAAGAACG TTTTCCAATG ATGAGCACTT TTAAAGTTCT GCTATGTGGC GC - #GGTATTAT1080# 1097             C- (2) INFORMATION FOR SEQ ID NO:8:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 3186 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#fluorescens) ORGANISM: Pseudomonas     (B) STRAIN: CGA267356 ( - #aka MOCG134 and aka BL915)-    (vii) IMMEDIATE SOURCE:     (B) CLONE: pCIB146-     (ix) FEATURE:     (A) NAME/KEY: RBS     (B) LOCATION: 245..251#/note= "potential ribosome binding          site"-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 256..3006#/product= "LemA"ER INFORMATION:#"LemA coding sequence."#ID NO:8: (xi) SEQUENCE DESCRIPTION: SEQ- GATCCGGGGA TGGCCGGCAG ATACGGGATT CATTGGCTTC TGCAAGTAAT TC - #TCAGTTGC  60- GCGATTATTC AAGATTGTCC GCGGCCGGGC AACCGACACC GGTCGACAAA AC - #GCTGGCCG 120- GGCGCCGAGA CATCCGAGCC ATTGCGCGGT CAATTTTGCG AAGAATGCCG TC - #AAGCAAAT 180- GGCTACACTG CGCAGGTGGT GCGCACCGGA CGTGCGCAGG GTTCATTCAA AA - #TGGCGTGG 240- TAGCAGGAGA GTTGCGTGCT TAAGAAACTG GGAATCAAAG GCCGCGTGCT GT - #TACTGACC 300- TTGCTGCCAA CCAGCCTGAT GGCGTTGGTA CTGGGCGGTT ATTTCACCTG GA - #TGCAGCAA 360- TCGGACCTGC AAACCCAGCT TCTGCACCGC GGCGAAATGA TCGCCGAGCA AC - #TGGCGCCC 420- CTGGTGGCTC CCGCCCTGGC CCACCAGGAC ACTTCCCTGC TGGAGCGCAT CG - #CCACCCAA 480- TCCCTGGAAC AGCAGGACGT GCGCGCAGTG ACTTTCCTCG CGCCCGACCG CA - #CGCCGCTG 540- GCCCATGCCG GCCCGAGCAT GCTCAACCAG GCGCCGACCG GCAACGGCAG CC - #AGCTGCTG 600- CAACGCACCG GCAGCGACGC CACCCGCTAT CTGCTGCCGG TATTCGGCCG CC - #ACCGCAAC 660- CTGGCCGGCG ACCTGATTCC CGACGAGTCC GACCGCCTGC TCGGCTGGGT CG - #AGCTGGAA 720- CTGTCCCATA ACAGCATGCT GCTGCGCGGC TACCGCAGCC TGTTCGCCAG CC - #TGCTGCTG 780- ATTACCGCCG GGCTGATCTG CACCGGCCTG CTGGCACTGC GCATGGGGCG AA - #CCATCAAC 840- GACCCGCTGA GCCAGATCAA ACAGGCCGTC ACCCAGCTCA AGGACGGCAA CC - #TGGAAACC 900- CGCCTGCCCT TGCTCGGCAG CCAGGAACTG GACGAGCTGG CCTCGGGCAT CA - #ACCGCATG 960- GCCGGCACCC TGCAGAATGC CCAGGAAGAA CTGCAGCACA GCATCGACCA GG - #CCACCGAG1020- GACGTCCGGC AAAACCTGGA GACCATCGAG ATCCAGAACA TCGAGCTGGA CC - #TGGCGCGC1080- AAGGAGGCCC TGGAGGCCAG CCGGATCAAG TCCGAATTCC TGGCCAACAT GA - #GCCATGAA1140- ATCCGCACGC CGCTCAACGG CATCCTCGGC TTCACTCATT TGTTGCAGAA AA - #GCGAGCTG1200- ACCCCGCGCC AGCTGGATTA CCTGGGCACC ATCGAAAAAT CCGCCGACAG CC - #TGCTGGGA1260- ATCATCAACG AAATTCTCGA CTTCTCGAAA ATCGAAGCCG GCAAGCTGGT GC - #TCGACAGC1320- ATTCCGTTCA ACCTGCGCGA CCTGTTGCAG GACACCCTGA CCATTCTCGC TC - #CGGCCGCC1380- CACGCCAAGC AGCTGGAACT GGTCAGCCTG GTGTATCGCG ATAGCCCGCT GT - #CGCTGGTG1440- GGCGACCCGC TGCGCCTCAA GCAGATCCTC ACCAATCTGG TGAGCAACGC CA - #TCAAGTTC1500- ACCCGCGAAG GCACCATCGT CGCCCGGGCC ATGCTTGAAG AGGAGCACGA AG - #ACAGCGTG1560- CAACTGCGCA TCAGCATTCA GGACACCGGC ATCGGCCTGT CGAACCAGGA CG - #TGCGCGCC1620- CTGTTCCAGG CGTTCAGCCA GGCCGACAAT TCGCTGTCGC GACAACCCGG CG - #GGACTGGC1680- CTGGGGCTGG TGATTTCCAA GCGCCTGATC GAACAGATGG GCGGCGAGAT CG - #GCGTCGAC1740- AGCACGCCCG GCGAAGGTTC GGAGTTCTGG ATCAGCCTGC GCCTGCCGAA AA - #CCCGCGAC1800- GACGCCGAAG ACCTGCCGGC CCCGCCGCTG CTCGGCAGGC GGGTCGCGGT CC - #TGGAAAAC1860- CATGAGCTGG CGCGCCAGGC CCTGCAGCAT CAACTCGAGG ACTGCGGCCT GG - #AAGTCACT1920- CCGTTCAACA CCCTGGAAGC CCTGACCAAC GGGGTGACCG GCGTGCACCA GA - #CCGACCAG1980- GCGATCGATC TGGCGGTCCT CGGCATCACC ACCAACGACA TGCTGCCGGA AC - #GCCTCAAC2040- CAGCACATCT GGGACCTCGA GCACCTGGGC TGCAAAGTCC TGGTGCTGTG CC - #CGACCACA2100- GAACAGACAC TCTTCCACCT GTCGGTGCCC AACCCTCACA GCCAGTTGCA GG - #CCAAACCG2160- GCGTGCACGC GCAAACTGCG GCGCGCCCTG GCCGACCTGG TCAACCCCAA GG - #TGGTGCGC2220- AGCGAGCCGA GCGAACCGAT CGCCAGCCGC CCGCCACGGG TGCTGTGTGT CG - #ATGACAAC2280- CCGGCCAACC TGCTGCTGGT GCAGACCCTG CTCGAAGACA TGGGCGCCAA AG - #TGCTCGCG2340- GTCGACAGCG GCTATGCGGC GGTCAAGGCG GTGCAGAGCG AGTCGTTCGA CC - #TGGTGATG2400- ATGGACGTGC AGATGCCCGG CATGGACGGT CGCCAGAGCA CCGAGGCGAT TC - #GCCAGTGG2460- GAAAGCGGGC GCAACTGCTC GCCGCTGCCG GTGATCGCCC TCACCGCCCA CG - #CCATGGCC2520- AACGAAAAAC GCGCGCTGCT GCAAAGCGGC ATGGACGATT ACCTGACCAA AC - #CCATCAGT2580- GAGCGGCAAC TGGCCCAGGT GGTGCTGAAG TGGACCGGCC TGGCCCTGCG CA - #ACCAAGGT2640- CCGGAACGCT CTGGCGAAGT GTCTGGCAAC GGCCTCGAGC TGCAAGTGCT GG - #ATCACGAC2700- GAAGGCTTGC TCCTGGCCGC CGGCAAGGCG GACCTGGCGG CCGACATGCT GG - #CCATGCTC2760- CTGGCCTCGC TGGAAGCCGA TCGCGAAGCG ATTCGCGCCG CCCGTGCCGC CA - #ACGATCAC2820- AATGCGTTGA TCGAGCGGGT CCATCGCCTG CACGGGGCGA CCCGCTATTG TG - #GCGTGCCG2880- CAGTTGCGCG CCGCCTGCCA GCGCAGCGAA ACCCTGCTCA AGCAGGAAGA CG - #TCAAGGCC2940- TTCGCCGCCC TCGACGAGCT CGAACGGGCC ATTAGTCGCC TGGCCACGGA GG - #CCCGCATC3000- AACGCCTGAT TCAAGGCAAC GACACGTCAG CCCCGCAGGT TCATGCTCGG GG - #CAACTTTC3060- ACAAGGACGA CGCCATGCGC ACGATTCTCT TCAGCAGCCA GAACTATGAC CG - #CGACAGCT3120- TCCTCGGCGC CGCCCTGCCG CCGGGCATCG AGCTGCAATT CCAGGCGGCG CG - #CCTGAGCC3180#         3186- (2) INFORMATION FOR SEQ ID NO:9:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 642 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-    (vii) IMMEDIATE SOURCE:     (B) CLONE: CGA375260-     (ix) FEATURE:     (A) NAME/KEY: CDS     (B) LOCATION: 1..639#/product= "gac*3 gene"ORMATION:#/transl-- except= (pos: 1 .. 3, aa: Met#ID NO:9: (xi) SEQUENCE DESCRIPTION: SEQ- TTG ATT AGG GTG CTA GTA GTC GAT GAC CAT GA - #T CTC GTT CGT ACA GGT  48Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- ATT ACA CGA ATG CTG GCT GAC ATC GAT GGC CT - #G CAA GTG GTC GGC CAG  96Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#            305- GCC GAG TCA GGG GAG GAA TCC CTG CTC AAG GC - #C CGG GAG TTG AAA CCC 144Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- GAT GTG GTC CTC ATG GAC GTC AAG ATG CCC GG - #G ATC GGC GGT CTT GAA 192Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- GCC ACG CGC AAA TTG TTG CGC AGT CAC CCG GA - #T ATC AAA GTC GTG GCC 240Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- GTC ACC GTG TGT GAA GAA GAT CCG TTC CCG AC - #C CGC TTG CTG CAA GCC 288Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- GGC GCG GCG GGT TAC CTG ACC AAG GGG GCG GG - #C CTC AAT GAA ATG GTG 336Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- CAG GCC ATT CGC CTG GTG TTT GCC GGC CAG CG - #T TAC ATC AGC CCG CAA 384Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- ATT GCC CAG CGG TTG GTG TTC AAG TCA TTC CA - #G CCT TCC AGT GAT TCA 432Ile Ala Gln Arg Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- CCG TTC GAT GCT TTG TCC GAG CGG GAA ATC CA - #G ATC GCG CTG ATG ATT 480Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- GTC GGC TGC CAG AAA GTG CAG ATC ATC TCC GA - #C AAG CTG TGC CTG TCT 528Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- CCG AAA ACC GTT AAT ACC TAC CGT TAC CGC AT - #C TTC GAA AAG CTC TCG 576Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- ATC AGC AGC GAT GTT GAA CTG ACA TTG CTG GC - #G GTT CGC CAC GGC ATG 624Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205# 642              CC TGAVal Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:10:-      (i) SEQUENCE CHARACTERISTICS:#acids    (A) LENGTH: 213 amino     (B) TYPE: amino acid     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: protein-           (xi) SEQUENCE DESCRIPTION: - # SEQ ID NO:10:- Met Ile Arg Val Leu Val Val Asp Asp His As - #p Leu Val Arg Thr Gly#                 15- Ile Thr Arg Met Leu Ala Asp Ile Asp Gly Le - #u Gln Val Val Gly Gln#             30- Ala Glu Ser Gly Glu Glu Ser Leu Leu Lys Al - #a Arg Glu Leu Lys Pro#         45- Asp Val Val Leu Met Asp Val Lys Met Pro Gl - #y Ile Gly Gly Leu Glu#     60- Ala Thr Arg Lys Leu Leu Arg Ser His Pro As - #p Ile Lys Val Val Ala# 80- Val Thr Val Cys Glu Glu Asp Pro Phe Pro Th - #r Arg Leu Leu Gln Ala#                 95- Gly Ala Ala Gly Tyr Leu Thr Lys Gly Ala Gl - #y Leu Asn Glu Met Val#           110- Gln Ala Ile Arg Leu Val Phe Ala Gly Gln Ar - #g Tyr Ile Ser Pro Gln#       125- Ile Ala Gln Arg Leu Val Phe Lys Ser Phe Gl - #n Pro Ser Ser Asp Ser#   140- Pro Phe Asp Ala Leu Ser Glu Arg Glu Ile Gl - #n Ile Ala Leu Met Ile145                 1 - #50                 1 - #55                 1 -#60- Val Gly Cys Gln Lys Val Gln Ile Ile Ser As - #p Lys Leu Cys Leu Ser#               175- Pro Lys Thr Val Asn Thr Tyr Arg Tyr Arg Il - #e Phe Glu Lys Leu Ser#           190- Ile Ser Ser Asp Val Glu Leu Thr Leu Leu Al - #a Val Arg His Gly Met#       205- Val Asp Ala Ser Ala    210- (2) INFORMATION FOR SEQ ID NO:11:-      (i) SEQUENCE CHARACTERISTICS:#pairs    (A) LENGTH: 5698 base     (B) TYPE: nucleic acid     (C) STRANDEDNESS: single     (D) TOPOLOGY: linear-     (ii) MOLECULE TYPE: DNA (genomic)-    (iii) HYPOTHETICAL: NO-     (iv) ANTI-SENSE: NO-     (vi) ORIGINAL SOURCE:#aureofaciens ORGANISM: Pseudomonas     (B) STRAIN: 30-84-    (vii) IMMEDIATE SOURCE:     (B) CLONE: phzFABCD-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 105..1307#/product= "phzF"ER INFORMATION:#"ORF1"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1323..1946#/product= "phzA"ER INFORMATION:#"ORF2"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 1943..3856#/product= "phzB"ER INFORMATION:#"ORF3"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 3859..4695#/product= "phzC"ER INFORMATION:#"ORF4"        /note=-     (ix) FEATURE:     (A) NAME/KEY: misc-- - #feature     (B) LOCATION: 4692..5360#/product= "phzD"ER INFORMATION:#"ORF5"        /note=#ID NO:11:(xi) SEQUENCE DESCRIPTION: SEQ- GAATTCATGA ACGTCTTTCA GCAACTGCGC GCCCTGGGTA TTCCAGTACC GC - #AAATCAAG  60- CGCGAAGGCA TTCCAACTTA ATCCCTCGTG AGAGTGATCG CATCATGGAA GA - #CTTACTGA 120- AACGGGTTTT AAGTTGTGAA GCGTTCCAGC AGCCTCAATG GAGCGAGCCC TC - #ACAATTGC 180- ATGACGCGCA GGCCTACCTC AGGGACAGCG CCTCATTGAT ACGAGTGGAA GA - #CATCCTGG 240- TGCTGCGCGC CACGCTGGCG CGTGTAGCGG CCGGCGAAGC AATGGTCATC CA - #GTCCGGTG 300- ACTGCGCCGA GGACATGGAT GAAAGCACTC CCGACCATGT GGCCCGCAAA GC - #CGCGGTAC 360- TGGACATCCT GGCCGGTACG TTCCGGCTGG TGACCCAACA ACCGGTGGTA CG - #GGTGGGAC 420- GAATTGCCGG GCAGTTTGCC AAGCCGCGTT CCAACAACAA CGAACGCATC GG - #CGATGTCG 480- AATTACCGGT GTATCGCGGC GACATGGTCA ACGGTCGCGA GGCCGTCTGC GG - #TCATCGCC 540- AGCACGATGC GCAACGCCTG GTTCGAGGCT ATAGCGCCGC GCGGGACATC AT - #GCAACACC 600- TGGGCTGGAA AGCCTCGGCA AGCCAGGAAC AACTCAGCGG TTCACCGGCC TG - #GACCAACC 660- ATGAAATGCT GGTACTCGAC TACGAACTGC CACAACTGCG CCAGGACGAA CA - #GGGCCGGG 720- TATTTCTCGG TTCTACCCAC TGGCCGTGGA TCGGCGAGCG TACCCGTCAG TT - #AACGGGCG 780- CTCACGTGAC GCTGCTCAGC GAAGTGCTCA ATCCGGTGGC GTGCAAGGTC GG - #CCCGGACA 840- TTACCCAAGA CCAGTTACTG AGCCTGTGTG AACGCCTGGA CGCCAAGCGC GA - #ACCCGGCC 900- GGCTGACCCT GATTGCCCGC ATGGGCGCGC AAAAGGTCGC CGAGCGCCTG CC - #GCCGCTGG 960- TCGAAGCGGT GCGCCAGGCC GGCCACAAGA TCATCTGGCT GAGCGACCCG AT - #GCACGGCA1020- ACACCATCGT CGCGCCCTGC GGCAACAAGA CCCGCATGGT GCAGGCCATC AC - #CGAGGAAA1080- TCGCCGCCTT CAAGCATGCC GTGACCTCCG CCGGTGGCGT GGCCGCCGGC CT - #GCACCTGG1140- AAACCACCCC TGACGACGTC AGCGAGTGCG CTTCCGATGC CGCCGGCCTG CA - #TCAGGTCG1200- CCAGCCGCTA CAAAAGCCTG TGCGACCCGC GCCTGAACCC CTGGCAAGCC AT - #TACTGCGG1260- TGATGGCCTG GAAAAACCAG CCCTCTTCAA CCCTTGCCTC CTTTTGACTG GA - #GTTTGTCG1320- TCATGACCGG CATTCCATCG ATCGTCCCTT ACGCCTTGCC TACCAACCGC GA - #CCTGCCCG1380- TCAACCTCGC GCAATGGAGC ATCGACCCCG AGCGTGCCGT GCTGCTGGTG CA - #TGACATGC1440- AGCGCTACTT CCTGCGGCCC TTGCCCGACG CCCTGCGTGA CGAAGTCGTG AG - #CAATGCCG1500- CGCGCATTCG CCAGTGGGCT GCCGACAACG GCGTTCCGGT GGCCTACACC GC - #CCAGCCCG1560- GCAGCATGAG CGAGGAGCAA CGCGGGCTGC TCAAGGACTT CTGGGGCCCG GG - #CATGAAGG1620- CCAGCCCCGC CGACCGCGAG GTGGTCGGCG CCCTGACGCC CAAGCCCGGC GA - #CTGGCTGC1680- TGACCAAGTG GCGCTACAGC GCGTTCTTCA ACTCCGACCT GCTGGAACGC AT - #GCGCGCCA1740- ACGGGCGCGA TCAGTTGATC CTGTGCGGGG TGTACGCCCA TGTCGGGGTA CT - #GATTTCCA1800- CCGTGGATGC CTACTCCAAC GATATCCAGC CGTTCCTCGT TGCCGACGCG AT - #CGCCGACT1860- TCAGCAAAGA GCACCACTGG ATGGCCATCG AATACGCCGC CAGCCGTTGC GC - #CATGGTCA1920- TCACCACCGA CGAGGTGGTG CTATGAGCCA GACCGCAGCC CACCTCATGG AA - #CGCATCCT1980- GCAACCGGCT CCCGAGCCGT TTGCCCTGTT GTACCGCCCG GAATCCAGTG GC - #CCCGGCCT2040- GCTGGACGTG CTGATCGGCG AAATGTCGGA ACCGCAGGTC CTGGCCGATA TC - #GACTTGCC2100- TGCCACCTCG ATCGGCGCGC CTCGCCTGGA TGTACTGGCG CTGATCCCCT AC - #CGCCAGAT2160- CGCCGAACGC GGTTTCGAGG CGGTGGACGA TGAGTCGCCG CTGCTGGCGA TG - #AACATCAC2220- CGAGCAGCAA TCCATCAGCA TCGAGCGCTT GCTGGGAATG CTGCCCAACG TG - #CCGATCCA2280- GTTGAACAGC GAACGCTTCG ACCTCAGCGA CGCGAGCTAC GCCGAGATCG TC - #AGCCAGGT2340- GATCGCCAAT GAAATCGGCT CCGGGGAAGG CGCCAACTTC GTCATCAAAC GC - #ACCTTCCT2400- GGCCGAGATC AGCGAATACG GCCCGGCCAG TGCGCTGTCG TTCTTTCGCC AT - #CTGCTGGA2460- ACGGGAGAAA GGCGCCTACT GGACGTTCAT CATCCACACC GGCAGCCGTA CC - #TTCGTGGG2520- TGCGTCCCCC GAGCGCCACA TCAGCATCAA GGATGGGCTC TCGGTGATGA AC - #CCCATCAG2580- CGGCACTTAC CGCTATCCGC CCGCCGGCCC CAACCTGTCG GAAGTCATGG AC - #TTCCTGGC2640- GGATCGCAAG GAAGCCGACG AGCTCTACAT GGTGGTGGAT GAAGAGCTGA AA - #ATGATGGC2700- GCGCATTTGT GAGGACGGCG GCCACGTCCT CGGCCCTTAC CTCAAGGAAA TG - #GCGCACCT2760- GGCCCACACC GAGTACTTCA TCGAAGGCAA GACCCATCGC GATGTACGGG AA - #ATCCTGCG2820- CGAAACCCTG TTTGCGCCCA CCGTCACCGG CAGCCCACTG GAAAGCGCCT GC - #CGGGTCAT2880- CCAGCGCTAT GAGCCGCAAG GCCGCGCGTA CTACAGCGGC ATGGCTGCGC TG - #ATCGGCAG2940- CGATGGCAAG GGCGGGCGTT CCCTGGACTC CGCGATCCTG ATTCGTACCG CC - #GACATCGA3000- TAACAGCGGC GAGGTGCGGA TCAGCGTGGG CTCGACCATC GTGCGCCATT CC - #GACCCGAT3060- GACCGAGGCT GCCGAAAGCC GGGCCAAGGC CACTGGCCTG ATCAGCGCAC TG - #AAAAACCA3120- GGCGCCCTCG CGCTTCGGCA ATCACCTGCA AGTGCGCGCC GCATTGGCCA GC - #CGCAATGC3180- CTACGTCTCG GACTTCTGGC TGATGGACAG CCAGCAGCGG GAGCAGATCC AG - #GCCGACTT3240- CAGTGGGCGC CAGGTGCTGA TCGTCGACGC CGAAGACACC TTCACCTCGA TG - #ATCGCCAA3300- GCAACTGCGG GCCCTGGGCC TGGTAGTGAC GGTGTGCAGC TTCAGCGACG AA - #TACAGCTT3360- TGAAGGCTAC GACCTGGTCA TCATGGGCCC CGGCCCCGGC AACCCGAGCG AA - #GTCCAACA3420- GCCGAAAATC AACCACCTGC ACGTGGCCAT CCGCTCCTTG CTCAGCCAGC AG - #CGGCCATT3480- CCTCGCGGTG TGCCTGAGCC ATCAGGTGCT GAGCCTGTGC CTGGGCCTGG AA - #CTGCAGCG3540- CAAAGCCATT CCCAACCAGG GCGTGCAAAA ACAGATCGAC CTGTTTGGCA AT - #GTCGAACG3600- GGTGGGTTTC TACAACACCT TCGCCGCCCA GAGCTCGAGT GACCGCCTGG AC - #ATCGACGG3660- CATCGGCACC GTCGAAATCA GCCGCGACAG CGAGACCGGC GAGGTGCATG CC - #CTGCGTGG3720- CCCCTCGTTC GCCTCCATGC AGTTTCATGC CGAGTCGCTG CTGACCCAGG AA - #GGTCCGCG3780- CATCATCGCC GACCTGCTGC GGCACGCCCT GATCCACACA CCTGTCGAGA AC - #AACGCTTC3840- GGCCGCCGGG AGATAACCAT GGAGCATTAC GTCATCATCG ACGCCTTTGC CA - #GCGTCCCG3900- CTGGAAGGCA ATCCGGTCGC GGTGTTCTTT GACGCCGATG ACTTGTCGGC CG - #AGCAAATG3960- CAACGCATTG CCCGGGAGAT GAACCTGTCG GAAACCACTT TCGTGCTCAA GC - #CACGTAAC4020- TGCGGCGATG CGCTGATCCG GATCTTCACC CCGGTCAACG AACTGCCCTT CG - #CCGGGCAC4080- CCGTTGCTGG GCACGGACAT TGCCCTGGGT GCGCGCACCG ACAATCACCG GC - #TGTTCCTG4140- GAAACCCAGA TGGGCACCAT CGCCTTTGAG CTGGAGCGCC AGAACGGCAG CG - #TCATCGCC4200- GCCAGCATGG ACCAGCCGAT ACCGACCTGG ACGGCCCTGG GGCGCGACGC CG - #AGTTGCTC4260- AAGGCCCTGG GCATCAGCGA CTCGACCTTT CCCATCGAGA TCTATCACAA CG - #GCCCGCGT4320- CATGTGTTTG TCGGCCTGCC AAGCATCGCC GCGCTGTCGG CCCTGCACCC CG - #ACCACCGT4380- GCCCTGTACA GCTTCCACGA CATGGCCATC AACTGTTTTG CCGGTGCGGG AC - #GGCGCTGG4440- CGCAGCCGGA TGTTCTCGCC GGCCTATGGG GTGGTCGAGG ATGCGGCCAC GG - #GCTCCGCT4500- GCCGGGCCCT TGGCGATCCA TCTGGCGCGG CATGGCCAGA TCGAGTTCGG CC - #AGCAGATC4560- GAAATTCTTC AGGGCGTGGA AATCGGCCGC CCCTCACTCA TGTTCGCCCG GG - #CCGAGGGC4620- CGCGCCGATC AACTGACGCG GGTCGAAGTA TCAGGCAATG GCATCACCTT CG - #GACGGGGG4680- ACCATCGTTC TATGAACAGT TCAGTACTAG GCAAGCCGCT GTTGGGTAAA GG - #CATGTCGG4740- AATCGCTGAC CGGCACACTG GATGCGCCGT TCCCCGAGTA CCAGAAGCCG CC - #TGCCGATC4800- CCATGAGCGT GCTGCACAAC TGGCTCGAAC GCGCACGCCG CGTGGGCATC CG - #CGAACCCC4860- GTGCGCTGGC GCTGGCCACG GCTGACAGCC AGGGCCGGCC TTCGACACGC AT - #CGTGGTGA4920- TCAGTGAGAT CAGTGACACC GGGGTGCTGT TCAGCACCCA TGCCGGAAGC CA - #GAAAGGCC4980- GCGAACTGAC AGAGAACCCC TGGGCCTCGG GGACGCTGTA TTGGCGCGAA AC - #CAGCCAGC5040- AGATCATCCT CAATGGCCAG GCCGTGCGCA TGCCGGATGC CAAGGCTGAC GA - #GGCCTGGT5100- TGAAGCGCCC TTATGCCACG CATCCGATGT CATCGGTGTC TCGCCAGAGT GA - #AGAACTCA5160- AGGATGTTCA AGCCATGCGC AACGCCGCCA GGGAACTGGC CGAGGTTCAA GG - #TCCGCTGC5220- CGCGTCCCGA GGGTTATTGC GTGTTTGAGT TACGGCTTGA ATCGCTGGAG TT - #CTGGGGTA5280- ACGGCGAGGA GCGCCTGCAT GAACGCTTGC GCTATGACCG CAGCGCTGAA GG - #CTGGAAAC5340- ATCGCCGGTT ACAGCCATAG GGTCCCGCGA TAAACATGCT TTGAAGTGCC TG - #GCTGCTCC5400- AGCTTCGAAC TCATTGCGCA AACTTCAACA CTTATGACAC CCGGTCAACA TG - #AGAAAAGT5460- CCAGATGCGA AAGAACGCGT ATTCGAAATA CCAAACAGAG AGTCCGGATC AC - #CAAAGTGT5520- GTAACGACAT TAACTCCTAT CTGAATTTTA TAGTTGCTCT AGAACGTTGT CC - #TTGACCCA5580- GCGATAGACA TCGGGCCAGA ACCTACATAA ACAAAGTCAG ACATTACTGA GG - #CTGCTACC5640- ATGCTAGATT TTCAAAACAA GCGTAAATAT CTGAAAAGTG CAGAATCCTT CA - #AAGCTT5698__________________________________________________________________________
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US5348742 *Apr 13, 1993Sep 20, 1994Ciba-Geigy CorporationAnti-pathogenic bacterial strains of Pseudomonas fluorescens
US5496547 *Jan 24, 1994Mar 5, 1996Ciba-Geigy CorporationPseudomonas biocontrol strains
EP0472494A2 *Aug 12, 1991Feb 26, 1992Ciba-Geigy AgAnti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics
WO1994001561A1 *Jul 2, 1993Jan 20, 1994J Ole BeckerGene activating element
WO1995033818A2 *May 30, 1995Dec 14, 1995James Joseph BeckGenes for the synthesis of antipathogenic substances
Non-Patent Citations
Reference
1Corbell et al., "A Global Regulator of Secondary Metabolite Production in Pseudomonas fluorescens PF-5", Journal of Bacteriology, 177(21): 6230-6236 (1995).
2 *Corbell et al., A Global Regulator of Secondary Metabolite Production in Pseudomonas fluorescens PF 5 , Journal of Bacteriology , 177(21): 6230 6236 (1995).
3Gaffney et al., "Global Regulation of Expression of Antifungal Factors by a Pseudomonas fluorescens Biological Control Strain", Molecular Plant-Microbe Interactions, 7(4): 455-463 (1994).
4 *Gaffney et al., Global Regulation of Expression of Antifungal Factors by a Pseudomonas fluorescens Biological Control Strain , Molecular Plant Microbe Interactions , 7(4): 455 463 (1994).
5Hrabak et al., "The lemA Gene Required for Pathogenicity of Pseudomonas syringae pv. Syringae on Bean Is a Member of a Family of Two-Component Regulators", J. of Bacteriology, 174(9): 3011-3020 (1992).
6 *Hrabak et al., The lemA Gene Required for Pathogenicity of Pseudomonas syringae pv. Syringae on Bean Is a Member of a Family of Two Component Regulators , J. of Bacteriology , 174(9): 3011 3020 (1992).
7Laville et al., "Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco", Proc. Natl. Acad. Sci., 39: 1562-1566 (1992).
8 *Laville et al., Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco , Proc. Natl. Acad. Sci. , 39: 1562 1566 (1992).
9Liao et al., "Molecular Characterization of Two Gene Loci Required for Production of the Key Pathogenicity Factor Pectate Lyase in Pseudomonas viridiflava", Molecular Plant-Microbe Interactions, 7(3): 391-400 (1994).
10 *Liao et al., Molecular Characterization of Two Gene Loci Required for Production of the Key Pathogenicity Factor Pectate Lyase in Pseudomonas viridiflava , Molecular Plant Microbe Interactions , 7(3): 391 400 (1994).
11Pierson et al., "Cloning and Heterologous Expression of the Phenazine Biosynthetic Locus from Pseudomonas aureofaciens 30-84", Molecular Plant-Microbe Interactions, 5(4): 330-339 (1992).
12 *Pierson et al., Cloning and Heterologous Expression of the Phenazine Biosynthetic Locus from Pseudomonas aureofaciens 30 84 , Molecular Plant Microbe Interactions , 5(4): 330 339 (1992).
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6743752Mar 28, 2003Jun 1, 2004Northern Quinoa CorporationApplying saponin/terpenes derived from quinoa or quillaja plants to tomato plants
US6881567Mar 15, 2002Apr 19, 2005Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agricultural And Agri-Food CanadaPre-emergent biological control agents
US6995007Jun 23, 2003Feb 7, 2006University Of MassachusettsAntifungal bacterium ATCC PTA-4838
US7666406Feb 2, 2006Feb 23, 2010University Of MassachusettsCarrier material is porous ceramic particles; biodegradation of toxins; compositions comprising inert carrier and microorganism associated with carrier material, particularly comprising inert carrier and strain that exhibits fungicidal activity for control of pathogenic fungi of medical significance
US8603824Jul 26, 2005Dec 10, 2013Pfenex, Inc.Process for improved protein expression by strain engineering
EP2434016A2Jan 18, 2005Mar 28, 2012Pfenex, Inc.Expression of mammalian proteins in Pseudomonas fluorescens
WO2001044447A1 *Dec 7, 2000Jun 21, 2001Chris BatieCompositions and methods for halogenation reactions
Classifications
U.S. Classification435/252.34, 424/93.4, 435/183, 424/93.2, 435/477, 435/476, 424/93.47, 435/69.1
International ClassificationA01N63/00
Cooperative ClassificationA01N63/00, C12R1/38
European ClassificationA01N63/00, C12R1/38
Legal Events
DateCodeEventDescription
Nov 18, 2003FPExpired due to failure to pay maintenance fee
Effective date: 20030921
Sep 22, 2003LAPSLapse for failure to pay maintenance fees
Apr 9, 2003REMIMaintenance fee reminder mailed
Apr 7, 1999ASAssignment
Owner name: NOVARTIS AG, SWITZERLAND
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIGON, JAMES M.;HILL, DWIGHT S.;TORKEWITZ, NANCY R.;AND OTHERS;REEL/FRAME:009874/0566;SIGNING DATES FROM 19990227 TO 19990329